Diese Seite ist auf Deutsch verfügbar. Zur deutschen Version.

COVID-19 Q&A’s

The Science behind COVID-19

Introduction

We are in the midst of the global COVID-19 pandemic, a severe respiratory disease caused by a Coronavirus called SARS-CoV-2. For a virus to cause a human pandemic, two conditions need to be met: the virus can be efficiently transmitted between humans and there is no pre-existing immunity against the new virus in the human population. In the absence of drugs or vaccines, the virus spreads unchecked. But what is this virus we have never met? Where does it come from? Why is it so infectious and how can our bodies fight it? How do we know how many of us are infected, and can we predict what the future of COVID-19 will look like?

  • What is a coronavirus? Gijs Versteeg, Immunologist
  • Where did COVID-19 come from? Manuela Baccarini, Cell Biologist
  • Why is SARS-CoV-2 so infectious? Thomas Leonard, Structural Biologist
  • How would my body fight a coronavirus infection? Thomas Decker, Immunologist
  • What is herd immunity? Pavel Kovarik, Immunologist
  • What are we doing to fight coronavirus? Tim Skern, Virologist
  • What is the future for COVID-19? Pavel Kovarik, Immunologist
  • On the origins of SARS-CoV-2: putting conspiracy theories to bed Thomas Leonard, Structural Biologist
  • Are COVID-19 numbers misleading? Manuela Baccarini, Cell Biologist
  • Mutation of SARS-CoV-2 – could it get worse? GijsVersteeg, Immunologist
  • In the quest for a cure: success stories and challenges Pavel Kovarik, Immunologist
  • A vaccine against SARS-CoV-2? Tim Skern, Virologist
  • Enhancing innate immunity – why Tb vaccines and interferons may help against COVID-19 Thomas Decker, Immunologist
  • External Sources

What is a coronavirus? Gijs Versteeg, Immunologist

Coronaviruses are readily recognizable from their spike-like projections on the surface of the virus particle. The crown-like shape of these spikes gives these viruses their name and is critical for the virus to infect its host.

 

Unlike other pathogens such as bacteria, viruses are not alive. If they are left on abiotic materials such as metal or plastic surfaces, they will not multiply. However, they can cause devastating disease when they infect humans. The reason is that in their core, viruses are packages for a piece of malicious genetic code. Upon delivery to human host tissues during infection, this code drives the production of viral factors that take over infected cells, and ensure the production and release of thousands of new infectious virus particles. These new virus particles in turn infect other cells, causing rapid virus spread and disease in the infected person.

The virus that causes the disease COVID-19 (SARS-CoV-2) packages its piece of malicious genetic code inside a lipid shell that is decorated with “Spike” structures. These spikes bind to specific receptors on lung and respiratory tract cells (called ACE-2), which fuses the virus particle with the host cell, delivers the genetic code, and starts the infection cycle. The bulky ends of the spikes give these viruses a crown-like shape (corona in Latin), from which their name is derived. The lipid shell in which the Spike proteins are anchored dissolves in soap when washing hands, rendering the virus particles non-infectious.

After entry, the released viral genetic material is decoded inside the infected cell into viral factors, thereby starting the hostile take-over of the infected cell, and production of new virus particles during the viral life cycle.

In addition to the spike, coronavirus particles are composed of structural components that both encapsulate the genetic code material (nucleocapsid) and give the virus particles their structure (membrane and envelope proteins). To replicate itself, the virus also encodes an enzyme to copy its genetic code (polymerase), and factors to inhibit the host’s immune defenses (accessory proteins). The accessory proteins are often important factors in determining the severity of disease, and may explain differences in the mortality rates between coronaviruses, such as SARS, MERS and COVID-19, that have claimed many lives in the last decade.

Where did COVID-19 come from? Manuela Baccarini, Cell Biologist

Coronaviruses infect many animal species as well as humans. COVID-19 is what’s called a ‘zoonosis’, which means that this disease jumped species into humans, probably through close contact with animals.

The causative agent of the disease COVID-19 is a coronavirus, (SARS-CoV-2). COVID-19 is a zoonosis, which means that it can be transmitted to humans from animals. Zoonoses caused by cross-species transmission represent 60% of the emerging infectious diseases worldwide, and are often life-threatening. We all remember the influenza pandemics caused by viruses that crossed the barrier from birds or swine to humans. Cross-species transmission often occurs when animals and humans are in close contact, such as large animal farms, or crowded food markets where live animals are sold. But how do these viruses make the jump to a new species? Ultimately, to infect a new host, the viral proteins involved in transmission must be able to bind to receptors present on the surface of cells in the new species. The changes usually arise from error-prone replication of the viral genome. As an example, the gene coding for the Spike protein, which binds to the receptor of SARS-CoV-2 in humans, is a mutational hotspot. Coronaviruses, like influenza viruses, can also exchange parts of their genome with other viruses during a coinfection. When such major genomic changes happen in the right region, they can generate new chimeric viruses capable of infecting a new host.

Zoonoses become really threatening when the viruses are able to efficiently spread from human to human, usually by droplet infection, as is the case for SARS-CoV-2 and related viruses – our species doesn’t “know” the virus and is therefore not protected. Identifying the species of origin and possible intermediate hosts is extremely important to be able to control future transmission events. In the case of COVID-19, full-length genome sequences of the SARS-CoV-2 virus obtained from patients (including a worker in the now infamous food market in Wuhan) are almost identical to that of coronaviruses found in bats.

However, Coronaviruses are in many animal species besides bats, and SARS-CoV-2 is not the only one that made the jump to ours. Of the 7 coronavirus isolated from humans, 4 cause common cold symptoms; the remaining 3 cause severe respiratory disease. The most similar to SARS-CoV-2 is SARS-CoV-1, responsible for the SARS (Severe Acute Respiratory Syndrome) outbreak originating in Guangdong, China in 2002, presumably originating from civet cats sold for food in a live-animal market, which were possibly infected by contact with bats. SARS spread rapidly to more than 30 countries, but luckily there have been no SARS cases since 2004. MERS-CoV was responsible for a 2012 outbreak with a clear epicenter in the Arabian Peninsula, and was traced to dromedary camels. Both viruses took a heavy toll on human health, but COVID-19 spreads with unprecedented speed and threatens to overwhelm health systems around the world. 

Why is SARS-CoV-2 so infectious? Thomas Leonard, Structural Biologist

SARS-CoV-2, the virus that causes COVID-19, binds tightly to the surface of cells that line our respiratory tract, while asymptomatic carriers spread the infection undetected. These two factors are contributing to COVID-19 spreading with unprecedented speed around the world. 

 

Like all viruses, SARS-CoV-2 requires a host in order to replicate itself. To replicate, the virus must first gain entry to the host cell. SARS-CoV-2 does this by latching on to a protein called ACE2, or angiotensin-converting enzyme 2, found on the surface of many cells in our bodies, including the delicate structures of the lungs that allow us to breathe. But why is Covid-19 different to other coronaviruses, including the one that caused the original SARS outbreak in 2002?

Scientists have now deciphered part of the answer to that question. The spike protein of SARS-CoV-2, which decorates the surface of the virus, binds to ACE2 on the surface of human cells 10 to 20 times more tightly than the original SARS coronavirus. Researchers have recently been able to obtain a snapshot of the spike protein bound to ACE2, revealing the reasons behind this difference. One can think of it like a jigsaw puzzle in which the two pieces fit perfectly together. The better the virus can bind to our cells, the more likely it is to gain entry.

The spread of the virus, however, is exacerbated by a second factor: asymptomatic carriers. These are people who exhibit no symptoms, but are carrying around the virus. Without knowing it, these people risk spreading the virus to others. For these reasons, the track-and-trace approach of widespread testing followed by strict quarantine, successfully employed in South Korea, is essential to contain the virus and avoid overwhelming healthcare services.

How would my body fight a coronavirus infection? Thomas Decker, Immunologist

Our immune system has two arms: the rapid reaction force, called ‘innate immunity’ and a slower arm, called ‘adaptive immunity’ which mounts a highly specific attack against the pathogen. Deployment of the adaptive arm of the immune system is essential to overcome the invader and to create a memory of the virus.

 

Our immune system protects us with weapons that are very rapidly deployed and others that take some time to start operating. Very simply put, the rapid response slows down the propagation of a virus, but cannot entirely stop it. The slow response is very effective and usually lets us regain health by clearing the virus from our body. The rapid and slow responses of our immune system are called innate and adaptive immunity.

Many viruses, including Corona viruses, actively reduce the impact of the rapid immune response. This allows them to multiply before the slower arm of the immune response starts being protective. In addition, some viral diseases, including severe cases of COVID-19, are associated with severe inflammation of internal organs, particularly the lung. In a worst-case scenario the resulting pneumonia impairs lung function to the point of being life-threatening.  A second threat is that a virally infected person becomes ‘superinfected’ with a second pathogen, usually a bacterium that exacerbates inflammation. We have no information as yet on how much superinfection contributes to COVID-19, but doctors have recommended people at high risk to be vaccinated against Pneumococcus, a frequent cause of pneumonia. 

Immunity as we understand it results from the slow arm of the immune system, the adaptive immunity. Figuratively speaking, adaptive immunity builds an army consisting of antibodies and cells that search and destroy the invading pathogen, and specifically generates a memory of this invader that helps it to mount a faster and more vigorous response to a secondary infection with the same pathogen. A characteristic of immunological defence and memory is the occurrence of neutralizing antibodies in the plasma of our blood. Antibodies are proteins that bind to the virus. If they are neutralizing they prevent the virus from attaching to cells it is trying to infect.

It is still early days to form a sound judgment of immunological memory as a means to prevent re-infection with the SARS-CoV-2 virus. However, neutralizing antibodies have been found in infected persons and there is reason to hope that immunological memory will indeed mitigate the risk of getting sick again with COVID-19.

What is herd immunity? Pavel Kovarik, Immunologist

Herd immunity occurs when transmission chains are disrupted by healthy people who are immune to the virus either through vaccination or having recovered from an earlier infection. Herd immunity is essential for the eradication of diseases such as smallpox, measles and polio.

Herd immunity (also called population immunity) is a mode of protection against infectious disease. It occurs when many individuals become immune by recovering from an earlier infection or through vaccination. Immune individuals do not contribute to disease transmission so that infection chains are frequently disrupted. Consequently, the infection spread is slowed or stopped in a population in which a high percentage of individuals possess immunity. For example, herd immunity generated through vaccination was a prerequisite for the eradication of smallpox in 1977. The proportion of people who need to become immune so that herd immunity can be established is different for each infection, depending on factors such as infectivity of the pathogen or the incubation period. Herd immunity is essential to protect vulnerable people, including the elderly and immune-compromised people, against an infection.

Models simulating the spread of COVID-19 disease suggest that 60-80% people need to be immune against the SARS-CoV-2 virus to establish an efficient herd immunity. Once this threshold is reached, the high-risk population, i.e. elderly or immunosuppressed people, and people with heart or lung diseases, would be to a large degree shielded from COVID-19. Broad testing for the presence of antibodies against the SARS-CoV-2 virus in the population will provide information on the current herd immunity and its progress.

What are we doing to fight coronavirus? Tim Skern, Virologist

Limiting the spread of COVID-19 is essential to prevent healthcare services from being overwhelmed. Together with its partners across Vienna, the Max Perutz Labs are repurposing existing research infrastructure to increase the national testing capacity.

 

 

Like many other countries around the world, Austria is suffering from a lack of testing capacity. In South Korea, where new infections have been successfully reduced to practically none, 1 in 136 people have been tested, a worldwide high. The ability to track and trace is key to ensuring the disruption of infection chains, quarantining infected people as soon as possible, and lowering the burden on health care services. In collaboration with 20 other research institutions across Vienna, the Max Perutz Labs are repurposing existing laboratory infrastructure, reagents and manpower to increase the national testing capacity for SARS-CoV-2.

But how does one test a person for SARS-CoV-2? Like all viruses, SARS-CoV-2 carries its own genetic code around with it. The complete genetic code of SARS-CoV-2 was determined from a patient in Wuhan, China in early January this year. Detecting the genetic instructions of the virus is key to the major test being used around the world. Using small pieces of DNA, called primers, that match specific regions of the SARS-CoV-2 code, scientists can make thousands of copies of these segments, allowing them to be detected. Since the same code does not exist in our own DNA, a positive result confirms the presence of the virus in our cells. However, testing capacity is currently limited by the availability of high-grade reagents and high-throughput pipelines to cope with demand. Our mission is to do what we can to enhance the current testing capacity by diverting existing resources to the cause.

Another way to detect the virus is to detect the immune response in infected patients. The antibodies that the body makes against the virus can be detected in a test that is called an Enzyme-Linked Immuno-Sorbent Assay, or ELISA for short. A virus-specific protein, made in a laboratory, is immobilized on a surface, allowing it to be probed with a blood sample taken from the patient. If the patient is infected or has recovered from an infection, antibodies against the viral protein will bind tightly to it. These antibodies are then detected in a second step that is coupled to a light-emitting or color-changing enzymatic reaction. Development of such a test is critical for assessing the level of immunity developing in a population. Since SARS-CoV-2 goes undetected in many asymptomatic carriers, it is difficult to estimate the number of people who are infected and the proportion that develop severe disease. The Max Perutz Labs and its partners are actively working towards the development and implementation of such a test.

What is the future for COVID-19? Pavel Kovarik, Immunologist

SARS-CoV-2 is still very new to us. Basic research is unraveling fundamental properties of the virus while clinical labs around the world are working with unprecedented speed to develop tools to stop its spread. As more and more is learned, predictions about the future of COVID-19 will become increasingly robust. 

People around the world are now asking what will be the future for the COVID-19 pandemic. Will the disease and the SARS-CoV-2 virus disappear, similar to SARS-CoV in 2004 and MERS-CoV in 2012? Or will the disease become part of our lives similar to flu? Will there be a treatment and/or vaccine? Definitive answers to these important questions are not available yet because the virus and the disease are new. However, based on current knowledge it is possible to discuss likely and less likely scenarios for the future of COVID-19.

The virus appears to be highly contagious; its infectivity is higher than that of coronaviruses in previous epidemics. This property contributes to the rapid spreading of the virus around the world. Moreover, the combination of a long incubation time (up to 2 weeks) with an extended period of virus shedding in COVID-19 patients (up to several weeks according to recent reports) and a high percentage of asymptomatic infections allows dissemination of the virus under the radar, thereby further worsening the pandemic. This fast growth in the number of infected people worldwide might help establish a herd immunity relatively soon, provided that recovered patients develop immunity to the virus. Fortunately, this appears to be the case: so far there is little evidence that patients can get re-infected with the virus. Thus, it can be assumed that most people can generate a protective immunity against the virus – this is good news for the development of vaccines against SARS-CoV-2. Vaccination would further facilitate the establishment of herd immunity and, consequently, perhaps eradication of the virus. Yet, viruses often have the unpleasant property of mutating their coat such that they cannot be recognized by the immune system, which was trained to attack the previous version of the virus. This is well known from the annual flu epidemics: every year a slightly different influenza virus evolves so that a lasting immunity against flu cannot be achieved. The available data on the mutation rate of SARS-CoV-2 provide grounds for some optimism: mutations in SARS-CoV-2 occur about two to four times slower than in the flu virus suggesting that immunity (generated during an infection or through vaccination) against SARS-CoV-2 could be more persistent than against flu.

In all likelihood, lasting strategies against COVID-19 will come from the research that is now spreading around the globe as quickly as the virus. Development of new drugs, re-purposing of known drugs, vaccination and other approaches are being pursued by companies and academic institutes worldwide, including those in Austria. Several promising results have already been achieved in the treatment of COVID-19 and the first vaccination trials have been initiated. The goals are clear: defeat the virus and learn the lessons so that we are better prepared for similar challenges in the future.

On the origins of SARS-CoV-2: putting conspiracy theories to bed Thomas Leonard, Structural Biologist

The media has widely reported claims that SARS-CoV-2 did not arise naturally but may have been deliberately created and released by scientists. The evidence, however, unequivocally supports a natural origin of the virus.

In April, concerns about a high-security virus facility in Wuhan, China, the epicenter of the COVID-19 outbreak, became the focus of media attention. Conspiracy theories rapidly circulated, ranging from an unfortunate accident to the more malicious deliberate engineering of a synthetic virus, the equivalent of an act of biological warfare. So what do we know about SARS-CoV-2 that can help us understand its origins?

Scientists have already been forensically examining the sequences of thousands of SARS-CoV-2 isolates. Fortunately, we know the genetic instructions of other coronaviruses as well as their mutation rates and biological processes that can change their genetic code. By comparing the genetic code of SARS-CoV-2 to those of other coronaviruses, scientists can date relatively accurately the likely time at which viruses diverged from a common ancestor. These in-depth analyses clearly demonstrate that the SARS-CoV-2 virus could not have occurred in a lab and is unlikely to have occurred in a pangolin. Most likely, SARS-CoV-2, like its cousin SARS-CoV from 2003, arose in a bat cave in the south-west of China some four decades ago.

SARS-CoV-2 contains a four amino acid insertion in part of its Spike protein that generates what is called a “furin cleavage site”. This means that the Spike can be cleaved by an enzyme in our cells, called furin; such cleavages have been shown to promote viral entry in related coronaviruses like the MERS virus. But where did this sequence come from? Sequence analysis of the SARS-CoV-2 genome strongly indicates that the sequence almost certainly did not arise from deliberate engineering of a bat coronavirus. Instead, the insertion likely arose from an event called a copy-choice error, which can arise when two or more related virus particles infect the same cell. In this co-infected cell, the enzyme that copies the viral genome (termed RNA polymerase) jumps from one virus’s RNA to another virus’s RNA during copying. As a consequence, RNA segments from two viruses are swapped leading to a novel combination of RNA molecules that did not previously exist. Indeed, the RNA sequence of the furin site insertion in SARS-CoV-2 is almost identical to that of the bat coronavirus HKU9 isolated in 2011, suggesting that HKU9 was one of the co-infecting viruses.

In summary: neither the part of the Spike protein that binds so effectively to our cells nor the furin cleavage site in the Spike protein arose by deliberate manipulation of a related virus. On the contrary, the above analyses show that the process was an entirely natural one that is frequently observed in coronaviruses, and has strong medical relevance in other viruses such as poliovirus and HIV.

Are COVID-19 numbers misleading? Manuela Baccarini, Cell Biologist

Have we flattened the curve? Can we resume our normal life? In a pandemic, the decision on how to proceed should be based on hard facts collected by epidemiologists.

Epidemiologists study patterns of disease in humans, including the number of infected individuals. These numbers have never been more available in real time than for the current COVID-19 pandemic. Many renowned institutions maintain websites through which we can watch the virus in action: how many cases in total, how many active cases – and the outcomes, recovered versus deaths. These numbers are the best we have and are used to make informed decisions. Unfortunately, however, they are at best a vague indication of our interaction with the virus.

The problem is that different countries use different methods to test and report COVID-19 cases. Why is this a problem? If we all test for the presence of the virus, we should all get the same results. However, diagnostic tests differ in sensitivity and in the probabilities of returning false positives and false negatives. In addition, some countries report both cases confirmed by laboratory tests and probable cases, defined as patients with symptoms who interacted with confirmed cases; suspected cases, i.e. patients that show COVID-19 symptoms but have neither been tested nor in contact with confirmed cases, are not reported. This also applies, of course to reporting COVID-19 as a cause of death. However, while deaths are certain, asymptomatic infections are invisible and therefore make up the largest contingent of unreported cases.

So how many COVID-19 cases are really out there? Nobody knows, but it is safe to assume that the actual number of cases is much higher than the numbers we read in the news. So if we really want to know how infectious the virus is and, by extension, what the true mortality rate is, there’s only one way: testing, testing, testing – and using standardized methods. The recent announcement by the Swiss pharmaceutical company Roche of a reliable ELISA test (see ‘What are we doing to fight coronavirus?’) is therefore welcome news.

Mutation of SARS-CoV-2 – could it get worse? GijsVersteeg, Immunologist

Viruses exploit error-prone replication of their genetic instructions to drive successful dissemination in their hosts. How does this work and what do we know about this process in SARS-CoV-2?

Humans have genetic material (DNA) that codes for all the factors that build up the different cells forming our bodies. Many viruses (including SARS-CoV-2) use a similar type of genetic material (RNA) to code for different, virus-specific factors needed for their life cycle. Two opposing biological principles in the replication of genetic material drive the evolutionary success of humans and viruses.

Humans are made up of many different cells, and copy their genetic material as precisely as possible when cells double during growth. The reason for this is that mistakes in just one of the many cells in a human body could be disastrous for the whole organism, as is, for example, the case when a single cell becomes cancerous.

In contrast, viruses thrive with the opposite strategy of replicating their genetic material with less fidelity, generating billions of progeny virus particles, each one slightly different from the other. Why would this be beneficial for the virus? Most of these changes are neutral or detrimental for infectivity, and will not be transmitted to other humans. However, a few of the viral genetic variants may now multiply faster, be transmitted more efficiently between individuals, or avoid recognition by antibodies generated by our immune systems. These viral variants will spread throughout the human population more efficiently.

The full genetic code of SARS-CoV-2 isolated from several thousand different COVID-19 patients has been determined; the viral genetic code is indeed showing signs of selection pressure. One of the genetic regions with alterations is the part encoding the viral entry protein (Spike), which may increase the strength of interaction of the virus with receptors on the surface of cells, or prevent efficient binding of otherwise neutralizing antibodies to it. Other alterations could potentially interfere with some of the current diagnostics. However, the influence of these mutations on viral fitness and virus detection remain unclear and will require further investigation.

In the quest for a cure: success stories and challenges Pavel Kovarik, Immunologist

Without a vaccine, what tools do we have to treat COVID-19? Can we actually treat the disease effectively or are we simply deploying lifeboats in the most urgent cases?

The reason for the global COVID-19 crisis is the lack of effective treatments. Current medication focuses on mitigation of the disease symptoms (symptomatic treatment) rather than on targeting the cause of the disease, i.e. the SARS-CoV-2 virus. Symptomatic treatment is a common strategy against many diseases, and it can also help against COVID-19. For example, severely sick COVID-19 patients receive oxygen to compensate for their lung insufficiency. Fever-reducing agents are another class of symptomatic medications for COVID-19. Promising symptomatic treatments are medications aimed at reducing the so called “cytokine storm” which is an immune reaction that has spiraled out of control and has a high risk of life-threatening lung damage.

Nevertheless, interventions directly targeting SARS-CoV-2 would tremendously enhance our ability to treat COVID-19. One such strategy employs the administration of blood serum obtained from people who recovered from COVID-19. The anti-SARS-CoV-2 antibodies present in these sera help the patients in multiple ways (for example, by preventing the virus from entering the cells). However, this successful therapy cannot be used on a large scale since the number of healthy serum donors is limited.

In the absence of a vaccine, drugs targeting the virus represent the best means for a broad and affordable treatment. One such drug is remdesivir, which interferes with the viral replication machinery. Originally developed against the Ebola virus, the drug appears to be also partially effective against SARS-CoV-2. However, drug repurposing has a high chance of failure. Chloroquine (a common anti-malarial drug) can block SARS-CoV-2 but has significant adverse side effects in COVID-19 patients. Drugs against the flu virus are, in general, ineffective against SARS-CoV-2. Thus, the challenge is to develop new drugs that are safe and precisely target SARS-CoV-2. Scientists are therefore searching for the Achilles’ heel in the SARS-CoV-2 life cycle that could be effectively targeted.

A vaccine against SARS-CoV-2? Tim Skern, Virologist

A vaccine, when available, will certainly be the most effective measure to control SARS-CoV-2. Before we look at the approaches being taken against SARS-CoV-2, let us look at how a vaccine works.

Vaccines are our most powerful health measure to prevent viral infections and thus protect ourselves against the diseases they cause. Simply put, a vaccine simulates a real infection in the body without the disease breaking out. The body then mounts a defense against these invaders that is memorised and can be reactivated should a genuine infection take place. Vaccines that protect against viral diseases come in three basic types. The most effective ones are called live vaccines. They contain a weakened virus (termed attenuated) that can still multiply in the body but without causing disease. Examples of this type are the measles and mumps vaccines. Inactivated viral vaccines (also referred to as killed vaccines) contain virus particles that have been chemically inactivated with for example formaldehyde. In contrast to live vaccines, they do not multiply but the viral particles are still recognised as foreign bodies so that the immune system can build a response. Inactivated vaccines, such as the one against tick-borne encephalitis virus (FSME), usually have to be injected more that once to ensure protection. The third types of viral vaccine, such as the flu vaccine, contain just certain parts of the virus that are required to generate protection.

Vaccines of all three types are being developed against SARS-CoV-2 by around 70 different institutes and companies. For instance, an inactivated vaccine is being tested in monkeys by a company in China. It will be many years before an attenuated vaccine against SARS-CoV-2 can be generated. Instead, researchers have turned to other viruses that can present the SARS-CoV-2 spike protein without causing disease. One promising approach that uses a monkey virus has already been shown to generate antibodies in humans against the related MERS virus. A similar vaccine against SARS-CoV-2 is now in clinical trials in humans. Even if current trials prove safe and show that antibodies are generated, it will still take many months to produce enough vaccine for the whole world. Until, then, the best methods to prevent infection by SARS-CoV-2 will remain social distancing and hand-washing with soap.

Enhancing innate immunity – why Tb vaccines and interferons may help against COVID-19 Thomas Decker, Immunologist

Vaccines harness the power of our adaptive immune system, but our innate immune system can also help. Here, we take a look at ways in which our innate immune system can work against SARS-CoV-2.

Immunological memory and immunity against pathogens are usually attributed to the adaptive immune system (see: How would my body fight a coronavirus infection?). However, this is not the whole truth. Our innate immune system also remembers a previous encounter with microorganisms or viruses. This innate memory, also called trained immunity, is fundamentally different from the memory lymphocytes and antibodies produced by the adaptive immune system.

The biggest difference is that our innate immune system acts broadly and not only against the same pathogen that caused the immune response in the first place. For example, animals treated with bacterial vaccines have been found to display enhanced immunity against a subsequent viral infection. Trained immunity by the innate immune system triggered researchers from the German Max Planck Society to develop the idea of using an improved and clinically approved vaccine against Tuberculosis (Tb) to protect against SARS-CoV-2. The scientists think the bacteria in the vaccine may help to harness the innate immune system against SARS-CoV-2. Since the vaccine is already approved for use, it can be tested immediately in clinical trials.

Another potentially helpful substance is interferon (IFN). IFN is released by our innate immune system as a response to viral infection. In fact, the name stems from its ability to ‘interfere’ with viral replication inside cells. Interferons are approved clinical treatments against cancer and viral infections. Thus, they could be tested in a small cohort of COVID-19 patients and were found to increase clearance of the virus in the upper respiratory tract. However, another study cautions against the use of IFN. The authors report that IFN increases expression of the receptor for SARS-CoV-2 entry (ACE2) on airway epithelial cells. Thus, beneficial and potentially harmful effects of IFN treatment must be carefully evaluated in future clinical trials.

03
Mon
06
Feb 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SHUKLA Vikas (Berger), VOICHEK Yoav (Nordborg), WIDEN Sonya (Burga)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
09
Feb 2023
VBC Regular Seminar

Single-cell driven enhancer modelling and design

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Stein AertsInstitute: VIB Center for Brain and Disease ResearchHost: Alex Stark

Mon
13
Feb 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: RODRIGUEZ TERRONES Diego (Tanaka), SESTINI Giovanni (Rivron), PETROULAKI Vasiliki (Matos)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
16
Feb 2023
VBC Regular Seminar

Cell stress and the evolution of novel cell types

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Günter WagnerInstitute: Yale University and University of ViennaHost: Elly Tanaka

Mon
20
Feb 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: BRUNNER Hanna (Haselbach), FRIDRICH Arie (Berger), AKULOVA Vasilina (Swarts)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Tue
21
Feb 2023
Vienna BioCenter Climate Lecture Series

Mitigation of climate change: how to use satellite observations to track actions?

  16:00 - 17:00
  Zoom

Speaker: Inge JonckheereInstitute: United Nations and IPPC Lead AuthorHost: Climate@Max Perutz Labs

Thu
23
Feb 2023
Impromptu Seminar

Translating science into survival

  14:00 - 15:00
  IMP Lecture Hall

Speaker: Christoph HuberInstitute: Universitätsmedizin Mainz, TRON gGmbH, BioNTechHost: Jürgen Knoblich

Thu
23
Feb 2023
VBC Regular Seminar

New insights in gene regulation and chromatin folding by enhancers and cohesin

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Wouter de LaatInstitute: Hubrecht InstituteHost: Christa Bücker

Mon
27
Feb 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: DE SANTIS Martina (Rivron), BUENDIA Daniel (Mari-Ordonez), ENGL Magdalena (Slade)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
27
Feb 2023
Impromptu Seminar

From plasma membrane, through ribosomes to the nuclear envelope

  10:00 - 11:00
  IMP Lecture Hall

Speaker: Juliette FedryInstitute: Bijvoet Center for Biomolecular Research, Utrecht UniversityHost: Andi Pauli

Thu
02
Mar 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Ron DrorInstitute: Stanford UniversityHost: David Haselbach

Mon
06
Mar 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: VOJTEK Matus (Stark), LEHMANN Christian (Knoblich), AUGUSTO Pedro (Zimmer)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
09
Mar 2023
VBC Regular Seminar

Designing and building a minimal divisome

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Petra SchwilleInstitute: MPI of BiochemistryHost: Alwin Köhler

Fri
10
Mar 2023
VBC Added Dimension Talk

Title to be announced

  16:00 - 17:00
  IMP Lecture Hall

Speaker: Tecumseh FitchInstitute: Dept. of Behavioral and Cognitive Biology, University of ViennaHost: Jan-Michael Peters, Clemens Plaschka

Fri
10
Mar 2023
IMP Impromptu Seminar

Genomic Analysis of Osteosarcoma: Making Sense of a Complex Genome to Advance Translational Research and Targeted Therapy

  11:00 - 12:00
  IMP Lecture Hall

Speaker: Alejandro Sweet-CorderoInstitute: University of California San FranciscoHost: Anna Obenauf

Mon
13
Mar 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SPICER Maximilian (Gerlich), ESTIVILL I CAPAAROS Guillem (Obenauf), MURPHY Paul (Clausen)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
16
Mar 2023
Seminar Series on Modern Concepts in Structural Biology

Title to be announced

  14:00 - 15:00
  VBC5 Lecture Hall A+B/Zoom

Speaker: Christoph RademacherInstitute: UNIVIE, Faculty of Life SciencesHost: Georg Kontaxis

Thu
16
Mar 2023
VBC Regular Seminar

Imaging of cell division across scales

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Jan EllenbergInstitute: EMBL HeidelbergHost: Shotaro Otsuka

Mon
20
Mar 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: JÄGER Christina (Van der Veeken), PRADHAN Saurabh (Rivron), RAFANEL Baptiste (Brennecke)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Tue
21
Mar 2023
New Developments in Chromosome Biology

Characterisation of Vpr1, a novel protein involved in DSB repair

  11:40 - 12:40
  VBC5 Lecture Hall A+B

Speaker: Mustafa AlaaboInstitute: Dept. Chromosome Biology, Univ. ViennaHost: Franz Klein

Tue
21
Mar 2023
Impromptu Seminar

Title to be announced

  10:00 - 11:00
  IMP Seminar Room 1.014/16

Speaker: Sandra LubitzInstitute: Evotec AGHost: Jennifer Volz-Glaser, IMBA SCCF

Wed
22
Mar 2023
Symposium

SY-Stem

  12:00 - 13:00
  IMP Lecture Hall
Mon
27
Mar 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: BUSETTO Virginia (Falk), HARVEY Zachary (Berger), MILOJKOVIC Lidija (Urban)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Tue
28
Mar 2023
New Developments in Chromosome Biology

m5C-modifications of ribosomal RNA modulate healthy lifespan and development

  11:40 - 12:40
  VBC5 Lecture Hall A+B

Speaker: Markus SchossererInstitute: Medical University ViennaHost: Christopher Campbell

Wed
29
Mar 2023
Seminar Series on Modern Concepts in Structural Biology

Title to be announced

  14:00 - 15:00
  VBC5 Lecture Hall A+B/Zoom

Speaker: Sebastian FürthauerInstitute: TU Vienna, Institute of Applied PhysicsHost: Bojan Zagrovic

Thu
30
Mar 2023
Seminar Series on Modern Concepts in Structural Biology

Title to be announced

  14:00 - 15:00
  VBC5 Lecture Hall A+B/Zoom

Speaker: Christian UngermannInstitute: University of OsnabrückHost: Gang Dong

Mon
03
Apr 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: PANAROTTO-PERICLES Melanie (Peters), KOLESNIKOVA Sofia (Gerlich), HANDLER Dominik (Brennecke)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
06
Apr 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Dirk InzeInstitute: VIBHost: Andreas Bachmair

Mon
17
Apr 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: BAUCELLS Julia (Dammermann), GOMEZ SEGALAS Alba (Balzarotti), VOICHEK Maya Shinan (Brennecke)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
20
Apr 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Maria LlorensInstitute: CBMHost: Noelia Urban

Mon
24
Apr 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: DMITRIEV Vladimir (Goloborodko), HISANAGA Tetsuya (Berger), KHALDIEH Nina (Ameres)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Tue
25
Apr 2023
SFB Meiosis Monthly Meeting

Visualization of Macromolecular Assemblies in Meiosis Using Cryo-Electron Tomography

  11:40 - 12:40
  VBC5 Lecture Hall A+B

Speaker: Jannik HugenerInstitute: ETH ZürichHost: Joao Matos

Tue
25
Apr 2023
Impromptu Seminar

Title to be announced

  11:00 - 12:00
  IMP Lecture Hall

Speaker: Arun K. ShuklaInstitute: Indian Institute of TechnologyHost: David Haselbach

Wed
26
Apr 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Kathrin LangInstitute: ETH ZurichHost: Tim Clausen

Wed
03
May 2023
Symposium

Microsymposium on Small RNA Biology

  09:00 - 10:00
  IMP Lecture Hall
Mon
08
May 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SOMMER Theresa (Rivron), SHIRZADIAN YAZD Mehrta (Balzarotti), VERTESY Abel (Knoblich)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Tue
09
May 2023
SFB Meiosis Monthly Meeting

Control of meiotic crossover placement in Drosophila

  11:40 - 12:40
  VBC5 Lecture Hall A+B

Speaker: Jeff SekelskyInstitute: UNC School of MedicineHost: Joao Matos

Wed
10
May 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Joanna WysockaInstitute: Stanford School of MedicineHost: Christa Bücker

Mon
15
May 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: POLIKARPOVA Anastasia (Tanaka), CHAKRABORTY Oisorjo (Grade), CORSI Flavia (Goloborodko)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Tue
16
May 2023
New Developments in Chromosome Biology

Identification of novel ciliogenesis genes using a phylogenetic profiling approach

  11:40 - 12:40
  VBC5 Lecture Hall A+B

Speaker: Alex DammermannInstitute: Dept. Microbiology, Immunbiology and Genetics, University ViennaHost: Verena Jantsch

Wed
17
May 2023
Max Birnstiel Lecture

Title to be announced

  11:00 - 12:00
  IMP Lecture Hall

Speaker: Andre NussenzweigInstitute: NIHHost: Jan-Michael Peters

Mon
22
May 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: KHAURATOVIC Uladzislava (Matos/Golobordko), SHEN Jingyi (Obenauf), FESSELET Jeanne (Kovarik)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
25
May 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Roger GeigerInstitute: Institute for Research in Biomedicine, BellinzonaHost: Joris Van der Veeken

Fri
02
Jun 2023
Impromptu Seminar

Probing chromosome mechanics in the interphase nucleus

  10:00 - 11:00
  GMI Orange Seminar Room

Speaker: Antoine CoulonInstitute: Institut CurieHost: Anton Goloborodko and Daniel Gerlich

Mon
05
Jun 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: PERNEBRINK Mattias (Tanaka), HOHMANN Ulrich (Brennecke/Plaschka), MANOLOVA Toni (Falk)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
12
Jun 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: WU Shuangyang (Dolan), SCARAMUZZA Federico (Tessmar), KROGULL Daniel (Burga)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
15
Jun 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Martin HetzerInstitute: IST AustriaHost: Jürgen Knoblich

Mon
19
Jun 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HEIDARI KHOEI Heidar (Rivron), ABDRAKHMANOV Alibek (Dagdas), GALUSKA Philipp (Djinovic)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
22
Jun 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Daniele CanzioInstitute: UCSFHost: Anton Goloborodko

Mon
26
Jun 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: WILLIAMS Thomas (Clausen), GEISMANN Maximilian (Balzarotti)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Tue
27
Jun 2023
SFB Meiosis Monthly Meeting

Comprehensive and quantitative characterization of aneuploidy phenotypes

  11:40 - 12:40
  VBC5 Lecture Hall A+B

Speaker: Manuela Sophie KollerInstitute: Dept. Chromosome Biology, Univ. ViennaHost: Chris Campbell

Mon
03
Jul 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: JELENIC Stela (Saha), PACHECO FIALLOS Franics Belen (Plaschka), FONTES OLIVEIRA Tiago Manuel (Penninger)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
10
Jul 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: NAGUMO WONG Sakurako (Knoblich), LORENZO ORTS Laura (Pauli), ROSS James (Burga)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
13
Jul 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Samer HattarInstitute: NIHHost: Kristin Tessmar

Mon
17
Jul 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: RAFFL Gerald (Ameres), SAJTOS Bettina (Zuber), ISHIHARA Keisuke (Tanaka)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
20
Jul 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Anshul KundajeInstitute: Stanford UniversityHost: Alex Stark

Mon
24
Jul 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: STEINACKER Thomas (Gerlich), EDER Stephanie (Zimmer), TIKANOVA Polina (Burga)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
31
Jul 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SCHELLHAAS Ulla (Plaschka/Ameres), RUSCH Emma (Goloborodko), VULIN Milica (Obenauf)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
07
Aug 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: RADHAKRISHNA PILLAI Balashankar (Saha), ADELMANN Leonie (Raible), BLAHA Andreas (Pauli)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
14
Aug 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: BELL Caelan (Gerlich), MEREITER Stefan (Penninger), BINDL Michael (Leeb)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
21
Aug 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LORBEER Franziska (Stark), MULVEY Hugh (Dolan), PÜHRINGER Florian (Burga)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
28
Aug 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HOLZER Elisabeth (Martens), COLOZZA Gabriele (Koo), FALCON CHAVEZ Francisco (Tanaka)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
28
Aug 2023
Symposium

SMLMS Meeting

  09:00 - 10:00
  IMP Lecture Hall
Sun
03
Sep 2023
Symposium

ISRB Meeting

  14:00 - 15:00
  IMP Lecture Hall
Mon
04
Sep 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: RÖHSNER Josef (Pauli), OKUN Anastasia (Karagöz), JUNG Pauline (Obenauf)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
07
Sep 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Sir Philip CohenInstitute: University of DundeeHost: Egon Ogris

Mon
11
Sep 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LICHT-MAYER Simon (Penninger), CAYGILL Samuel (Dolan), MIGOTTI Mario (Konrat)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
14
Sep 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Feng ShaoInstitute: National Institute of Biological Sciences, BeijingHost: Pavel Kovarik

Mon
18
Sep 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SHUNMUGAM Dhanlakshmi (Baccarini), CECI GINISTRELLI Lavinia (Mendjan), VORLÄNDER Matthias (Plaschka)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Wed
20
Sep 2023
Max Birnstiel Lecture

Title to be announced

  11:00 - 12:00
  IMP Lecture Hall

Speaker: Jan LöweInstitute: MRC Laboratory of Molecular BiologyHost: Jan-Michael Peters

Thu
21
Sep 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Lydia FinleyInstitute: Memorial Sloan Kettering Cancer CenterHost: Johannes Zuber

Mon
25
Sep 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: KOK Jian Yi (Berger), GROH Roan (Dagdas), SODERHOLM Adrian (Versteeg)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
28
Sep 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Stephan GruberInstitute: University of LausanneHost: Franz Klein

Mon
02
Oct 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: STRAVS Ana (Knoblich), SANCHEZ DE MEDINA HERNANDEZ Victor (Dagdas), KRUMWIEDE Luisa (Gaidt)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
09
Oct 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: TAVERINI Katherina (Urban), CORIC Aida (Tessmar)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
12
Oct 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Nancy KlecknerInstitute: Harvard UniversityHost: Franz Klein

Mon
16
Oct 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: GRABARCZYK Daniel (Clausen), PROTELL I DE MONTSERRAT Julia (Brennecke/Plaschka), MANCHENO JUNCOSA Estela (Mendjan)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
19
Oct 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Edward LemkeInstitute: IMB MainzHost: David Haselbach

Mon
23
Oct 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: ATTRILL Sarah (Dolan), UIJTTEWAAL Esther (Elling), SCIBISZ Grzegorz (Karagöz)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
30
Oct 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: DOLESCHALL Balint (Knoblich), FENG Sonjie (Bücker), BOURGUET Pierre (Berger)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
02
Nov 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Rotem SorekInstitute: Weizmann Institute of Science, RehovotHost: Julius Brennecke

Mon
06
Nov 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HORENKAMP Simone (Tanaka), CASEY Chloe (Dolan), KAPRAL Thomas (Zagrovic)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
09
Nov 2023
Symposium

VBC PhD Symposium

  09:00 - 10:00
  IMP Lecture Hall
Mon
13
Nov 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: KOBAKHIDZE George (Dong), ANGELOPOULOU Eleni (Ellis), PACHANO Tomas (Stark)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
16
Nov 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Stephan GrillInstitute: MPI of Molecular Cell Biology and GeneticsHost: Clemens Plaschka

Mon
20
Nov 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: RAMIREZ America (Köhler), VÖLKL Isabella (Bücker), HOANG Oi Pui (Technau)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
23
Nov 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Mounia LaghaInstitute: Institut de Genetique Moleculaire de MontpellierHost: Andrea Pauli

Mon
27
Nov 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LEITNER Moritz (Martinez), VOGEL Alexander (Yudushkin), KETTEL Paulina (Karagöz)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
04
Dec 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: TSAREV Aleksandr (Ameres), FIESELER Charlie (Zimmer), ABESAMIS Kim Ivan (Dong)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
07
Dec 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Laurent NguyenInstitute: University of LiegeHost: Noelia Urban

Mon
11
Dec 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: KLEIFELD Justus (Urban), ORLIC Lucija (Matos)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu
14
Dec 2023
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Ian HicksonInstitute: University of CopenhagenHost: Joao Matos

Mon
18
Dec 2023
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SHULKINA Alexandra (Versteeg), GEETHA Sowmya (Jantsch), MADHUSUDHANAN Jalaja (Zimmer)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
08
Jan 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: KOLLER Manuela (Campbell), GUPTA Ankit (Goloborodko), SCHMÖLLERL Johannes (Zuber)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
15
Jan 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: MARCHIORI Elisa (Van der Veeken), ACHLEITNER Anja (Martens), FAAS Victoria (Clausen)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
22
Jan 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SALEWSKIJ Kirill (Penninger), KIRCHGATTERER Paul (Gaidt), REN Kaike (Otsuka)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
29
Jan 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: MIHAILOVIC Milica (Karagöz), BELL Lillie (Clausen), TELONI Federico (Gerlich)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
05
Feb 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: STANKUNAS Edvinas (Köhler), CASEY Alexandra (Dolan), LEV Itamar (Zimmer)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
12
Feb 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: OBERHUEMER Michael (Leeb), GONAZLEZ ALVARADO Maria (Grade), SCHOLZ Julia (Otsuka)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
19
Feb 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: AMANN Sascha (Haselbach), KASHKO Nataliia (Matos), BAUER Bernd (Martens)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
26
Feb 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LEE Joonsun (Elling), LEYVA GONZALEZ Marco (Tanaka), MILIVOJEV Nadja (Raible)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
04
Mar 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: GAO Peng (Dagdas), GOGOVA Rebeca (Clausen), PAVLOVA Anzhela (Matos)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
11
Mar 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: AYALA MUNOZ Farja (Plaschka), VETRANO Pamela (Ramundo), YU Changwei (Brennecke)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
18
Mar 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: KONSTANTINOU Andri (Obenauf), NAVA GARCIA Marintia (Dagdas), WOLFF Uyen Le Phuong (Jantsch V.)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
25
Mar 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HARTMANN Felix (Matos), PASSERA Alessandro (Balzarotti), SANCHEZ BURGOS Laura (Obenauf)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
08
Apr 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HAIDER Jakob (Gaidt), HODAKOVA Zuzana (Haselbach), MYLARSHCHIKOV Dmitry (Gerlich)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Tue
09
Apr 2024
Mendel Lecture

Title to be announced

  11:00 - 12:00
  IMP Lecture Hall

Speaker: Johannes WalterInstitute: Harvard Medical SchoolHost: Jan-Michael Peters

Mon
15
Apr 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: PIECH Lucas (Leonard), DE LA CONCEPCION Juan Carlos (Dagdas), POPOVA Mariia (Peters)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
22
Apr 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: GALLI Lucrezia (Tanaka), DIAS Ana Beatriz (Slade), TAKACS Zsuzsanna (Gerlich)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
29
Apr 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: KNIEST Judith (Haselbach), KELLNER Max (Penninger), BABADEI Olga (Decker)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
06
May 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: BOHAUMILITZKY Lena (Pinheiro), RAIDERS Stephan (Tanaka), PRLESI Ines (Gerlich)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
13
May 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: PANDA Aswini (Saha), PITASI Mattia (Leeb), HEINZL Monika (Stark)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
27
May 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: VELETI Lalitha (Pauli), FORISCH Stephan (Elling), NAAS Julia (Van Haeseler)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
03
Jun 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: FARAWAY Rupert (Plaschka), GRUNDMANN Lorenz (Haselbach), KLEINWAECHTER Ava (Slade)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
10
Jun 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: RÖTZER Johannes (Dolan), MIOCIC-STOSIC Fran (Zagrovic), RITSCHKA Birgit (Tanaka)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
17
Jun 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: PUSHPA BOSE Greeshma (Urban), ROGOWSKI Nicole (Elling), RAINA Shiviya (Dammermann)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
24
Jun 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: COUTURIER Jeanne (Jachowicz), PABST Gabriel (Zuber), ROFFAY Chloe (Pinheiro)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
01
Jul 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: RUSSETT Colleen (Berger), NAJM Ramsey (Knoblich), HOLLAUS David (Gaidt)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
08
Jul 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SHARMA Sanskriti (Ellis), JANKOWSKA Julia (Ameres), PAPAREDDY Ranjith (Dagdas)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
15
Jul 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: MAURER Eric (Peters), BHARDWAJ Vishakha (Schlögelhofer), DIEZMA Laura (Nordborg/Mari-Ordonez)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
22
Jul 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: GUZMAN PEREZ Sebastian (Martinez), LITTLEBOY Jamie (Knoblich), RIABOV Daria (Plaschka)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
29
Jul 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: ZEILER Christina (Kovarik), DOCAVO GARCIA Antonio (Jachowicz), DEIBER Sebastian (Dolan)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
05
Aug 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: ZMAJKOVIC Jakub (Zuber), DEL CHIARO Alessia (Dagdas), ANTONIOLI Sumire (Leonard)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
12
Aug 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HUETTER Christiane (Menche), KRACHT Laura (Knoblich), SANDRU Ana Maria (Baccarini)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
19
Aug 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: BENEDUM Johannes (Slade), KALIS Robert (Zuber), PATEL Rajvi (Matos)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon
26
Aug 2024
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: PROTSENKO Liudmila (Brennecke), SHETTY Kavya (Hein), BASSAT Elad (Tanaka)Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

  • Name
    Phone
    Mail
    Function
    Group
    Room
  • Yeseniia Bobrynova
    +43-1-4277-56231
    Diploma/Master Student
    Matos
    5.122/5.123
    Main Building
  • A
  • Kim Ivan Abesamis
    +43-1-4277-61626
    PhD Student
    Dong
    3.127
    Main Building
  • Sonja Achleitner
    +43-1-4277-54632
    PhD Student
    Martens
    5.401
    Main Building
  • Leonie Adelmann
    +43-1-4277-54616
    PhD Student
    Raible
    4.115
    Main Building
  • Marlene Adlhart
    +43-1-4277-52272
    Technician
    Zagrovic
    1.114
    VBC 5
  • Elias Adriaenssens
    +43-1-4277-52828
    PostDoc
    Martens
    5.401
    Main Building
  • Vasilina Akulova
    +43-1-4277-74320
    PhD Student
    Swarts
    1.722.1
    VBC 5
  • Mustafa Alaabo
    +43-1-4277-56221
    Klein
    5.528/5.530
    Main Building
  • Sadia Sabrina Alam
    +43-1-4277-52810
    PhD Student
    Bachmair
    5.108/5.109
    Main Building
  • Tanino Albanese
    +43-1-4277-54632
    PhD Student
    4.129
    Main Building
  • Santiago Alonso Gil
    +43-1-4277-52272
    PostDoc
    Zagrovic
    1.114
    VBC 5
  • Manuel Alonso Y Adell
    +43-1-4277-52808
    PostDoc
    Campbell
    5.512/5.513
    Main Building
  • Thomas Altmutter
    +43-1-4277-24003
    Administration
    3.117
    Main Building
  • Stefan Ameres
    +43-1-4277-54693
    Group Leader
    Ameres
    2.119
    Main Building
  • Gabriele Andreatta
    +43-1-4277-74636
    PostDoc
    Tessmar
    4.501
    Main Building
  • Eleni Angelopoulou
    +43-1-4277-74649
    PhD Student
    Ellis
    3.121
    Main Building
  • Aleksandra Anisimova
    +43-1-4277-61653
    PhD Student
    Karagöz
    3.502
    Main Building
  • Dorothea Anrather
    +43-1-4277-52846
    Senior Proteomics Specialist
    E72
  • Sumire Antonioli
    +43-1-4277-52241
    PhD Student
    Leonard
    1.222
    VBC 5
  • Lisa Appel
    +43-1-4277-52807
    PostDoc
    Slade
    5.508
    Main Building
  • Alexis Arizpe
    +43-1-79044-9942
    PhD Student
    Swarts
    1104
    VBC 5
  • Hossein Arzani
    +43-1-4277-61812
    PhD Student
    Kuchler
    2.107
    Main Building
  • Igor Asanovic
    +43-1-4277-61815
    PhD Student
    Martinez
    2.512
    Main Building
  • Gerlinde Aschauer
    +43-1-4277-52851
    Program manager
    5.119
    Main Building
  • Nataliia Atamas
    +43-1-4277-52229
    PostDoc
    Konrat
    0612
    VBC 5
  • Zahra Ayatollahi
    +43-1-4277-61609
    Administration
    Martens
    3.518
    Main Building
  • Daniel Aziz
    +43-1-4277-74320
    Diploma/Master Student
    Juffmann
    1.722
    VBC 5
  • B
  • Olga Babadei
    +43-1-4277-54628
    PhD Student
    Decker
    4.522/4.524
    Main Building
  • Julia Babel
    +43-1-4277-56221
    Klein
    5.528/5.530
    Main Building
  • Manuela Baccarini
    +43-1-4277-54607
    Group Leader
    Baccarini
    4.628
    Main Building
  • Andreas Bachmair
    +43-1-4277-74811
    Group Leader
    Bachmair
    5.110
    Main Building
  • Gergely Bakocai
    +43-1-4277-61785
    Lab Assistant
    2.527
    Main Building
  • Elizabeta Banic Ochsenhofer
    +43-1-4277-54621
    PostDoc
    Dammermann
    4.508
    Main Building
  • Matthias Bärnthaler
    +43-1-4277-24041
    Head of IT
    4.420
    Main Building
  • Andrea Barta
    +43-1-4277-61640
    Lecturer
    Barta
    3.520
    Main Building
  • Antoine Baudrimont
    +43-1-4277-56261
    PostDoc
    Jantsch V
    5.522
    Main Building
  • Bernd Bauer
    +43-1-4277-24001
    PhD Student
    Martens
    5.503
    Main Building
  • Verena Baumann
    +43-1-4277-52838
    PostDoc
    Martens
    5.401
    Main Building
  • Clara Beer
    +43-1-4277-74601
    Diploma/Master Student
    Witte
    4.125/4.127
    Main Building
  • Nikolaus Beer
    +43-1-4277-52801
    Diploma/Master Student
    Ameres
    2.125
    Main Building
  • Andreas Beier
    +43-1-4277-52227
    PhD Student
    Konrat
    0614
    VBC 5
  • Helen Belalcazar
    +43-1-4277-61628
    PostDoc
    Köhler A
    3.527
    Main Building
  • Andrej Belokurov
    +43-1-4277-24080
    Facility Technician
    Tessmar
    0.413
    Main Building
  • Johannes Benedum
    +43-1-4277-52807
    PhD Student
    Slade
    5.508
    Main Building
  • Christian Bernhart
    +43-1-4277-52812
    IT Support
    5.617
    Main Building
  • Annika Bestehorn
    +43-1-4277-54626
    PhD Student
    Kovarik
    4.514
    Main Building
  • VISHAKHA BHARDWAJ
    +43-1-4277-56241
    PhD Student
    Schlögelhofer
    5.524/5.526
    Main Building
  • Michael Bindl
    +43-1-4277-61645
    PhD Student
    Leeb
    3.123/3.125
    Main Building
  • Head of Biooptics Facility
    +43-1-4277-61672
    PostDoc
    1.618
    VBC 5
  • Nora Bischoff
    +43-1-4277-54625
    Technician
    Kovarik
    4.514
    Main Building
  • Tamires Bitencourt
    +43-1-4277-61819
    Kuchler
    2.509
    Main Building
  • Dieter Blaas
    +43-1-4277-61630
    Lecturer
    Blaas
    3.520
    Main Building
  • Udo Bläsi
    +43-1-4277-54609
    Group Leader
    Bläsi
    4.121
    Main Building
  • Sonja Bleichert
    +43-1-4277-74649
    Technician
    Ellis
    3.121
    Main Building
  • Margaryta Borysova
    +43-1-4277-24080
    Facility Manager
    Raible
    0.413
    Main Building
  • Helena Bragulat Teixidor
    +43-1-4277-61668
    PhD Student
    Otsuka
    3.505
    Main Building
  • Daniel Braun
    +43-1-4277-52227
    PostDoc
    Konrat
    0614
    VBC 5
  • Helena Brezovec
    +43-1-4277-74636
    Tessmar
    4.504/4.506
    Main Building
  • Barbara Brumec
    +43-1-4277-61661
    Technician
    3.518
    Main Building
  • Judith BRUYERE
    +43-1-4277-61656
    Falk
    1.624
    VBC 5
  • Stefania Bucconi
    +43-1-4277-74645
    Technician
    Leeb
    3.123/3.125
    Main Building
  • Chloé Bucheron
    +43-1-4277-74371
    Diploma/Master Student
    Menche
    1.104
    Main Building
  • Valentina Budroni
    +43-1-4277-54164
    PhD Student
    Versteeg
    4.108
    Main Building
  • Christa Buecker
    +43-1-4277-74646
    Group Leader
    Bücker
    3.626
    Main Building
  • Anna Burger
    +43-1-4277-24061
    Facility Technician
    8.318
    Main Building
  • Sebastian Burgstaller-Muehlbacher
    +43-1-4277-74324
    PostDoc
    v. Haeseler
    1.812.4
    VBC 5
  • Virginia Busetto
    +43-1-4277-74320
    PostDoc
    Falk
    1.624
    VBC 5
  • C
  • Christopher Campbell
    +43-1-4277-52808
    Group Leader
    Campbell
    5.610
    Main Building
  • Leandro Cannizzaro
    +43-1-4277-54629
    Technician
    Baccarini
    4.525/4.527
    Main Building
  • Oliviero Carugo
    +43-1-4277-52208
    Djinovic
    1.120
    VBC 5
  • Irene Ceccolini
    +43-1-4277-52229
    PhD Student
    Konrat
    0614
    VBC 5
  • Chiara Ceriotti
    +43-1-79730-3450
    5.10
    IMP/IMBA
  • Luis Miguel Cerron Alvan
    +43-1-4277-74645
    PhD Student
    Leeb
    3.123/3.125
    Main Building
  • Ronit Chakraborty
    +43-1-4277-54628
    Diploma/Master Student
    Kovarik
    4.514
    Main Building
  • Weiqiang Chen
    +43-1-4277-52846
    Proteomics Specialist
    E72
  • Doris Chen
    +43-1-4277-74328
    PostDoc
    Klein
    1.812.3
    VBC 5
  • Martin Chiettini
    +43-1-4277-74390
    Technician
    Menche
    1803
    VBC 5
  • Marius Constantin Chirita Mihaila
    +43-1-4277-52213
    PhD Student
    Juffmann
    1.614
    VBC 5
  • Anastasia Cianciulli Sesso
    +43-1-4277-54631
    PhD Student
    Bläsi
    4.122/4.124
    Main Building
  • Clara Conrad-Billroth
    +43-1-4277-52213
    PhD Student
    Juffmann
    1.614
    VBC 5
  • Aida Coric
    +43-1-4277-74636
    PhD Student
    Tessmar
    4.501
    Main Building
  • Renate Coufal
    +43-1-4277-24071
    Facility Manager
    1.117
    Main Building
  • Kitti Dora Csalyi
    +43-1-4277-24051
    Facility Head
    2.530
    Main Building
  • Andrea Czerny
    +43-1-4277-61606
    Lab Assistant
    3.515
    Main Building
  • D
  • Alexander Dammermann
    +43-1-4277-54681
    Group Leader
    Dammermann
    4.609
    Main Building
  • Beltran Davis
    +43-1-4277-54607
    PostDoc
    Baccarini
    4.525/4.527
    Main Building
  • Thomas Decker
    +43-1-4277-54605
    Group Leader
    Decker
    4.112
    Main Building
  • Isabel Del Pino Gomez
    +43-1-4277-54601
    Lab Assistant
    4.211/4.411
    Main Building
  • Pallavi Deolal
    +43-1-4277-61668
    PostDoc
    Otsuka
    3.505
    Main Building
  • Sebastian Didusch
    +43-1-4277-54629
    PhD Student
    Baccarini
    4.525/4.527
    Main Building
  • Ines Dittrich
    +43-1-4277-56241
    Technician
    5.524/5.526
    Main Building
  • Kristina Djinovic-Carugo
    +43-1-4277-52203
    Group Leader
    Djinovic
    1.606
    VBC 5
  • Jeroen Dobbelaere
    +43-1-4277-54619
    PostDoc
    Dammermann
    4.510/4.512
    Main Building
  • Gang Dong
    +43-1-4277-61625
    Group Leader
    Dong
    3.626
    Main Building
  • Kevin Doppelmayer
    +43-1-4277-54626
    Diploma/Master Student
    Kovarik
    4.516
    Main Building
  • Corinne Drexler
    +43-1-4277-52866
    PhD Student
    Fuchs
    5.506
    Main Building
  • Sharif Duale
    +43-1-4277-61785
    Technician
    Köhler A
    3.514
    Main Building
  • Monika Ducka
    +43-1-4277-74825
    Technician
    Ameres
    2.126
    Main Building
  • E
  • Karin Ehrenreiter
    +43-1-4277-54617
    Administration
    Baccarini
    4.114
    Main Building
  • Michael Eigenschink
    +43-1-4277-61669
    Müllner
    2.524
    Main Building
  • Christiane Elgert
    +43-1-4277-74325
    PostDoc
    v. Haeseler
    1.812.4
    VBC 5
  • Stephanie Ellis
    +43-1-4277-74648
    Group Leader
    Ellis
    3.118
    Main Building
  • Colette Emery
    +43-1-4277-54621
    Diploma/Master Student
    Dammermann
    4.508
    Main Building
  • Magdalena Engl
    +43-1-4277-52807
    PhD Student
    Slade
    5.508
    Main Building
  • Rainer Ettelt
    +43-1-4277-54630
    PhD Student
    Baccarini
    4.529
    Main Building
  • F
  • Martin Fahrenberger
    +43-1-4277-74330
    PhD Student
    v. Haeseler
    1.812.2
    VBC 5
  • Sebastian Falk
    +43-1-4277-74360
    Group Leader
    Falk
    1.620
    VBC 5
  • Anna Falkner
    +43-1-4277-52807
    Technician
    Slade
    5.508
    Main Building
  • Michel Fasnacht
    +43-1-4277-54632
    Senior PostDoc
    Moll
    4.129
    Main Building
  • Renate Fauland
    +43-1-4277-50115
    Administration
    6.111a
    Main Building
  • Songjie Feng
    +43-1-4277-74647
    PhD Student
    Bücker
    3.510/3.512
    Main Building
  • Luca Ferrari
    +43-1-4277-52828
    PostDoc
    Martens
    5.502
    Main Building
  • Jeanne Fesselet
    +43-1-4277-54626
    PhD Student
    Kovarik
    4.516
    Main Building
  • Daria Filipczak
    +43-1-4277-61681
    PhD Student
    Foisner
    3.110
    Main Building
  • Felix Fischer
    +43-1-4277-52272
    Diploma/Master Student
    Zagrovic
    1.114
    VBC 5
  • Patrick Fischer
    +43-1-4277-52807
    Slade
    5.610
    Main Building
  • Sabine Fischer
    +43-1-4277-24014
    Administration
    3.117
    Main Building
  • Irmgard Fischer
    +43-1-4277-52866
    Imaging Specialist (In House Microscopes)
    5.401
    Main Building
  • Roland Foisner
    +43-1-4277-61680
    Group Leader
    Foisner
    3.113
    Main Building
  • Maurizio Forte
    +43-1-4277-54626
    PhD Student
    Kovarik
    4.516
    Main Building
  • Magdalena Fritz
    +43-1-4277-61707
    Müllner
    2.530
    Main Building
  • Ingrid Frohner
    +43-1-4277-61740
    PostDoc
    Ogris
    2.130
    Main Building
  • Johanna Fromherz
    +43-1-4277-61741
    Ogris
    2.130
    Main Building
  • Peter Fuchs
    +43-1-4277-52855
    Group Leader
    Fuchs
    5.024
    Main Building
  • Sándor Fülöp
    +43-1-4277-24013
    Administration
    3.117
    Main Building
  • G
  • Laura Gallego
    +43-1-4277-61641
    PostDoc
    Köhler A
    3.522
    Main Building
  • Philipp Galuska
    +43-1-4277-52263
    PhD Student
    Djinovic
    0114
    VBC 5
  • Julia Garcia Baucells
    +43-1-4277-24001
    PhD Student
    Dammermann
    4.508
    Main Building
  • David Gaßner
    +43-1-4277-61626
    Diploma/Master Student
    Dong
    3.127
    Main Building
  • Kirsten Gassner
    +43-1-4277-54643
    Diploma/Master Student
    Witte
    4.125/4.127
    Main Building
  • Konstantina Georgiou
    +43-1-4277-61681
    PhD Student
    Foisner
    3.110
    Main Building
  • Devon Germain
    +43-1-4277-61823
    PostDoc
    Martinez
    2.515
    Main Building
  • Tanja Gesell
    +43-1-4277-52292
    1.610
    VBC 5
  • Netsanet Getachew
    +43-1-4277-74636
    Technician
    Raible
    4.501
    Main Building
  • Julia Gobl
    +43-1-4277-52275
    Leonard
    1.321.1
    VBC 5
  • Anastasiia Gorbenkova
    +43-1-4277-61815
    Diploma/Master Student
    Martinez
    2.515
    Main Building
  • Boris Görke
    +43-1-4277-54603
    Group Leader
    Görke
    4.113
    Main Building
  • Irene Gösler
    +43-1-4277-61673
    Lab Manager
    Foisner
    3.108
    Main Building
  • Josef Gotzmann
    +43-1-4277-61672
    Head of Facility
    1.618
    VBC 5
  • Angela Graf
    +43-1-4277-56261
    Technician
    Jantsch V
    5.522
    Main Building
  • Claudia Graf
    +43-1-4277-24012
    Administration
    6.109
    Main Building
  • Lucas Grandits
    +43-1-4277-72523
    Diploma/Master Student
    Juffmann
    1.614
    VBC 5
  • Christa Gregori-Schüller
    +43-1-4277-61806
    PostDoc
    Kuchler
    2.111
    Main Building
  • Katarzyna Gruber
    +43-1-4277-24075
    Lab Assistant
    1.117
    Main Building
  • Iris Gruber
    +43-1-4277-74320
    Administration
    v. Haeseler
    1.604
    VBC 5
  • Juliane Gruber
    +43-1-4277-52807
    Diploma/Master Student
    Slade
    5.508
    Main Building
  • Julia Guthrie
    +43-1-4277-74372
    PostDoc
    Menche
    1104
    VBC 5
  • Sebastian Guzman Perez
    +43-1-4277-61821
    Martinez
    2.512
    Main Building
  • Attila György
    +43-1-4277-24060
    Technicial Management
    3.501
    Main Building
  • H
  • Kathrin Hacker
    +43-1-4277-74638
    Technician
    Versteeg
    4.108
    Main Building
  • Thomas Haden
    +43-1-4277-24042
    IT Support
    2.116
    Main Building
  • Leila Hadziabdic
    +43-1-4277-54632
    PhD Student
    Moll
    4.129
    Main Building
  • Simon Haendeler
    +43-1-4277-74329
    PhD Student
    v. Haeseler
    1.812.2
    VBC 5
  • Sören Häfker
    +43-1-4277-74641
    PostDoc
    Tessmar
    4.504/4.506
    Main Building
  • Anna Hakobyan
    +43-1-4277-74390
    PhD Student
    Menche
    1803
    VBC 5
  • Barbara Hamilton
    +43-1-4277-52814
    Administration
    6.111a
    Main Building
  • Joel Hancock
    +43-1-4277-74390
    PhD Student
    Menche
    1803
    VBC 5
  • Robert Happel
    +43-1-4277-74322
    IT Support
    v. Haeseler
    1.812.1
    VBC 5
  • Andreas Hartig
    +43-1-4277- 52817
    Lecturer
    Hartig
    5.110
    Main Building
  • Natascha Hartl
    +43-1-4277-52846
    Senior Technician
    E72
  • Markus Hartl
    +43-1-4277-52846
    Head of Facility
    5.10
    IMP/IMBA
  • Felix Hartmann
    +43-1-4277-52862
    PhD Student
    Matos
    5.125/5.127
    Main Building
  • Lisa Haselbach
    +43-1-4277-61801
    Administration
    2.115
    Main Building
  • Marco Hein
    +43-1-4277-61701
    Group Leader
    Hein
    2.115
    Main Building
  • Adrian Henggeler
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Joachim Hermisson
    +43-1-4277-74351
    Group Leader
    Hermisson
    1.722.1
    VBC 5
  • Felix Hitzelhammer
    +43-1-4277-52213
    Diploma/Master Student
    Juffmann
    1.722
    VBC 5
  • Reinhold Hofbauer
    +43-1-4277-61750
    Lecturer
    Hofbauer
    2.519
    Main Building
  • Juergen Hoffmann
    +43-1-4277-90-52213
    Technician
    1.620
    VBC 5
  • Michael Hoffmann
    +43-1-4277-52229
    Diploma/Master Student
    Konrat
    0614
    VBC 5
  • Franziska Hofstetter
    +43-1-4277-61761
    Diploma/Master Student
    Weitzer
    2.522
    Main Building
  • Theresa Höfurthner
    +43-1-4277-52263
    PhD Student
    Konrat
    0114
    VBC 5
  • Laurenz Holcik
    +43-1-4277-74325
    PhD Student
    v. Haeseler
    1.812.3
    VBC 5
  • David Hollenstein
    +43-1-4277-52846
    Senior PostDoc
    E72
  • Elisabeth Holzer
    +43-1-4277-52828
    PhD Student
    Martens
    5.502
    Main Building
  • Julian Holzinger
    +43-1-4277-52229
    PostDoc
    Konrat
    0614
    VBC 5
  • Harald Hornegger
    +43-1-4277-61653
    PhD Student
    Karagöz
    3.507/ 3.508
    Main Building
  • Marie Huber
    +43-1-4277-74647
    Technician
    Bücker
    3.510/3.512
    Main Building
  • Theresa Hügel
    +43-1-4277-74640
    Program manager
    4.116
    Main Building
  • Tarik Husremovic
    +43-1-4277-52241
    Leonard
    1.321
    VBC 5
  • Michelle Huth
    +43-1-4277-74645
    PhD Student
    Leeb
    3.123/3.125
    Main Building
  • Christiane Hütter
    +43-1-4277-74390
    PhD Student
    Menche
    1803
    VBC 5
  • I
  • Bushra Ijaz
    +43-1-4277-52810
    Bachmair
    5.108/5.109
    Main Building
  • Kyojiro Ikeda
    +43-1-4277-74636
    PostDoc
    Raible
    4.501
    Main Building
  • Natale-Erwin Ivessa
    +43-1-4277-61805
    Lecturer
    Ivessa
    2.118
    Main Building
  • Luis Ixquiac
    +43-1-4277-52213
    Diploma/Master Student
    Juffmann
    1.722
    VBC 5
  • J
  • Hanieh Jafarian
    +43-1-4277-72524
    PhD Student
    Juffmann
    1.722
    VBC 5
  • Julia Jankowska
    +43-1-4277-74822
    PhD Student
    Ameres
    2.125
    Main Building
  • Verena Jantsch-Plunger
    +43-1-4277-56250
    Group Leader
    Jantsch V
    5.118
    Main Building
  • Swathi Jayaram
    +43-1-4277-74646
    PhD Student
    Bücker
    3.510/3.512
    Main Building
  • Ermire Jerliu
    +43-1-4277-54613
    Diploma/Master Student
    Witte
    4.125/4.127
    Main Building
  • Christina Jones
    +43-1-4277-3.123
    Diploma/Master Student
    Leeb
    3.123/3.125
    Main Building
  • Celia Jordá Fernández
    +43-1-4277-24001
    Diploma/Master Student
    Baccarini
    4.520
    Main Building
  • Isha Joshi
    +43-1-4277-56240
    PhD Student
    Schlögelhofer
    5.524/5.526
    Main Building
  • Aleksandra Jovanovic
    +43-1-4277-52806
    Lab Manager
    Ammerer
    2.122
    Main Building
  • Thomas Juffmann
    +43-1-4277-72520
    Group Leader
    Juffmann
    1.610
    VBC 5
  • Jose Julian Valenzuela
    +43-1-4277-52810
    PostDoc
    Bachmair
    5.108/5.109
    Main Building
  • Elisabeth Jursa
    +43-1-4277-52875
    Lab Assistant
    5.325
    Main Building
  • K
  • Lisa Kainz
    +43-1-4277-56221
    Klein
    5.528/5.530
    Main Building
  • Manfred Kaiser
    +43-1-4277-74328
    Diploma/Master Student
    v. Haeseler
    1.812.3
    VBC 5
  • Lakshmi Kalathinkunnath
    +43-1-4277-74636
    PhD Student
    Tessmar
    4.501
    Main Building
  • Petra-Franziska Kalman
    +43-1-4277-61831
    Lab Manager
    Martinez
    2.522
    Main Building
  • Stefan Emmerich Kalmár
    +43-1-4277-24065
    Head Technical Facility Management
    3.501
    Main Building
  • Thomas Kapral
    +43-1-4277-52272
    PhD Student
    Zagrovic
    1.114
    VBC 5
  • Arda Kara
    +43-1-4277-61626
    Diploma/Master Student
    Dong
    3.127
    Main Building
  • Elif Karagöz
    +43-1-4277-61635
    Group Leader
    Karagöz
    3.609
    Main Building
  • Nataliia Kashko
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Ruben Kastner
    +43-1-4277-56241
    Apprentice
    Schlögelhofer
    5.524/5.526
    Main Building
  • Clemens Kauffmann
    +43-1-4277-52229
    PostDoc
    Konrat
    0614
    VBC 5
  • Helga Kaufmann
    +43-1-4277-52801
    Lab Assistant
    5.210/5.410
    Main Building
  • Manpreet Kaur
    +43-1-4277-52213
    PhD Student
    Juffmann
    1.722
    VBC 5
  • Paulina Kettel
    +43-1-4277-61653
    PhD Student
    Karagöz
    3.507/ 3.508
    Main Building
  • Nina Khaldieh
    +43-1-4277-52801
    PhD Student
    Ameres
    2.122
    Main Building
  • AMEYA RAKESH KHANDEKAR
    +43-1-4277-74649
    PhD Student
    Ellis
    3.121
    Main Building
  • Uladzislava Khauratovich
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Sami Khawam
    +43-1-4277-74320
    PostDoc
    Juffmann
    1.610
    VBC 5
  • Narakorn Khunweeraphong
    +43-1-4277-61818
    PostDoc
    Kuchler
    2.509
    Main Building
  • Franz Klein
    +43-1-4277-56220
    Group Leader
    Klein
    5.114
    Main Building
  • Ava Kleinwaechter
    +43-1-4277-52807
    PhD Student
    Slade
    5.508
    Main Building
  • Tamara Klockner
    +43-1-4277-52808
    PhD Student
    Campbell
    5.512/5.513
    Main Building
  • Judith Kniest
    +43-1-4277-56240
    PhD Student
    Schlögelhofer
    5.623
    Main Building
  • Sonja Knödlstorfer
    +43-1-4277-52260
    PhD Student
    Konrat
    0122
    VBC 5
  • George Kobakhidze
    +43-1-4277-61626
    PhD Student
    Dong
    3.127
    Main Building
  • Julia Kober
    +43-1-4277-61761
    Diploma/Master Student
    Weitzer
    2.522
    Main Building
  • Anna Koch
    +43-1-4277-52814
    Diploma/Master Student
    Witte
    4.125/4.127
    Main Building
  • Anne Barbara Koehle
    +43-1-4277-56261
    Diploma/Master Student
    Jantsch V
    5.522
    Main Building
  • Katharina Kogler
    +43-1-4277-56221
    Klein
    5.528/5.530
    Main Building
  • Alwin Köhler
    +43-1-4277-61685
    Group Leader
    Köhler A
    3.520
    Main Building
  • Claudia Kölbl
    +43-1-4277-56261
    Diploma/Master Student
    Jantsch V
    5.522
    Main Building
  • Manuela Sophie Koller
    +43-1-4277-53808
    PhD Student
    Campbell
    5.512/5.513
    Main Building
  • Benjamin Koltschik
    +43-1-4277-4125
    Diploma/Master Student
    Witte
    4.125/4.127
    Main Building
  • Dhaarsini Koneswarakantha
    +43-1-4277-61821
    PostDoc
    Martinez
    2.515
    Main Building
  • Werner König
    +43-1-4277-52210
    Technician
    1.608
    VBC 5
  • Robert Konrat
    +43-1-4277-52202
    Group Leader
    Konrat
    1.602
    VBC 5
  • Georg Kontaxis
    +43-1-4277-52218
    Facility Manager
    1.608
    VBC 5
  • Katharina Korbula
    +43-1-4277-61626
    Lab Manager
    Dong
    3.127
    Main Building
  • Pavel Kovarik
    +43-1-4277-54608
    Group Leader
    Kovarik
    4.615
    Main Building
  • Saskia Kowald
    +43-1-4277-74644
    Diploma/Master Student
    Leeb
    3.123/3.125
    Main Building
  • Heinrich Kowalski
    +43-1-4277-61612
    Group Leader
    Kowalski
    3.516
    Main Building
  • Fiona Krammer
    +43-1-4277-74645
    Diploma/Master Student
    Leeb
    3.123/3.125
    Main Building
  • Kevin Alexander Kranz
    +43-1-4277-74361
    Diploma/Master Student
    Falk
    1.624
    VBC 5
  • Karl Kuchler
    +43-1-4277-61807
    Group Leader
    Kuchler
    2.111
    Main Building
  • Julius Kühn
    +43-1-4277-54629
    Diploma/Master Student
    Baccarini
    4.525/4.527
    Main Building
  • Claudia Kuntner
    +43-1-4277-56221
    Diploma/Master Student
    Klein
    5.528/5.530
    Main Building
  • Patricia-Emanuela Kutin
    +43-1-4277-61606
    Lab Assistant
    3.515
    Main Building
  • L
  • Karin Ledolter
    +43-1-4277-52260
    Lab Manager
    Konrat
    0122
    VBC 5
  • Martin Leeb
    +43-1-4277-74644
    Group Leader
    Leeb
    3.123/3.125
    Main Building
  • Günther Leitgeb
    +43-1-4277-54633
    IT Management
    4.420
    Main Building
  • Moritz Leitner
    +43-1-4277-61816
    PhD Student
    Martinez
    2.512
    Main Building
  • Thomas Lenert
    +43-1-4277-61602
    Administration
    3.115
    Main Building
  • Thomas Leonard
    +43-1-4277-52205
    Group Leader
    Leonard
    1.616
    VBC 5
  • Alina Leuchtenberger
    +43-1-4277-74330
    PhD Student
    v. Haeseler
    1.812.2
    VBC 5
  • Wei Chiang Liao
    +43-1-4277-61761
    Weitzer
    2.522
    Main Building
  • Raffael Lichtenberger
    +43-1-4277-61656
    Lab Manager
    Falk
    1.624
    VBC 5
  • Sarah Linauer
    +43-1-4277-61704
    Technician
    Ogris
    2.127
    Main Building
  • Josef Loidl
    +43-1-4277-56210
    Group Leader
    Loidl
    5.515
    Main Building
  • Salvo Danilo Lombardo
    +43-1-4277-74390
    PhD Student
    Menche
    1803
    VBC 5
  • M
  • Moritz Madern
    +43-1-79044-4291
    E72
  • Dante Maestre
    +43-1-4277-52213
    PhD Student
    Juffmann
    1.722
    VBC 5
  • Philipp Mairinger
    +43-1-4277-61656
    Diploma/Master Student
    Falk
    1.624
    VBC 5
  • Daniel Malzl
    +43-1-4277-74390
    PhD Student
    Menche
    1803
    VBC 5
  • Toni Manolova
    +43-1-4277-61656
    PhD Student
    Falk
    1.624
    VBC 5
  • Raphaël Marchand
    +43-1-4277-72523
    PostDoc
    Juffmann
    1.614
    VBC 5
  • Ana Markovic
    +43-1-4277-52808
    Diploma/Master Student
    Campbell
    5.610
    Main Building
  • Theodor Marsoner
    +43-1-4277-52808
    PhD Student
    Campbell
    5.512/5.513
    Main Building
  • Sascha Martens
    +43-1-4277-52876
    Group Leader
    Martens
    5.113
    Main Building
  • Javier Martinez
    +43-1-4277-61803
    Group Leader
    Martinez
    2.113
    Main Building
  • Fabien Martins
    +43-1-4277-24010
    Financial Director
    6.107
    Main Building
  • Angela Martins
    +43-1-4277-54601
    Administration
    4.114
    Main Building
  • Iryna Martsun
    +43-1-4277-47310
    Diploma/Master Student
    Tessmar
    0.413
    Main Building
  • Audrey Mat
    +43-1-4277-54618
    PostDoc
    Tessmar
    4.510/4.512
    Main Building
  • Joao Matos
    +43-1-4277-74419
    Group Leader
    Matos
    5.024
    Main Building
  • Theresa Matzinger
    +43-1-4277-61761
    Technician
    Weitzer
    2.522
    Main Building
  • Rounik Mazumdar
    +43-1-4277-61818
    PostDoc
    Kuchler
    2.505
    Main Building
  • Jörg Menche
    +43-1-4277-74370
    Group Leader
    Menche
    1804
    VBC 5
  • Mario Migotti
    +43-1-4277-52263
    PhD Student
    Konrat
    0114
    VBC 5
  • Milica Mihailovic
    +43-1-4277-61635
    PhD Student
    Karagöz
    3.502
    Main Building
  • Nadja Milivojev
    +43-1-4277-74636
    PhD Student
    Raible
    4.510/4.512
    Main Building
  • Frane Miljkovic
    +43-1-4277-61643
    PhD Student
    Köhler A
    3.524
    Main Building
  • Fran Miocic-Stosic
    +43-1-4277-52272
    PhD Student
    Zagrovic
    1.114
    VBC 5
  • Isabella Moll
    +43-1-4277-54606
    Group Leader
    Moll
    4.028
    Main Building
  • Giasemi Angeliki Moraitou
    +43-1-4277-56241
    Diploma/Master Student
    Schlögelhofer
    5.524/5.526
    Main Building
  • Ingrid Mudrak
    +43-1-4277-61740
    Lab Manager
    Ogris
    2.030
    Main Building
  • Amra Mujadzic
    +43-1-4277-52810
    Bachmair
    5.108/5.109
    Main Building
  • Felix Müller
    +43-1-4277-74371
    Senior PostDoc
    Menche
    1104
    VBC 5
  • Fränze Müller
    +43-1-4277-4282
    PostDoc
    Jantsch V
    5.623
    Main Building
  • Ernst Müllner
    +43-1-4277-61783
    Group Leader
    Müllner
    2.523
    Main Building
  • Melitta Münster
    +43-1-4277-52275
    Technician
    Zagrovic
    1.321
    VBC 5
  • Adnan Muratovic
    +43-1-4277-61653
    Diploma/Master Student
    Karagöz
    3.507/ 3.508
    Main Building
  • N
  • Julia Naas
    +43-1-4277-74328
    PhD Student
    v. Haeseler
    1.812.3
    VBC 5
  • Nana Naetar-Kerenyi
    +43-1-4277-61671
    PostDoc
    Foisner
    3.108
    Main Building
  • Valentina Nakic
    +43-1-4277-61761
    Weitzer
    2.522
    Main Building
  • Tsimafei Navalayeu
    +43-1-4277-52801
    PhD Student
    Ameres
    2.125
    Main Building
  • Lilian Nehlin
    +43-1-4277-52810
    PostDoc
    Bachmair
    5.108/5.109
    Main Building
  • Melissa Neumann
    +43-1-4277-24072
    Facility Staff
    0.116
    Main Building
  • Isabell Niedermoser
    +43-1-4277-61653
    Technician
    Karagöz
    3.507/ 3.508
    Main Building
  • Yap Shing Nim
    +43-1-4277-61649
    PostDoc
    Köhler A
    3.527
    Main Building
  • Johannes Nimpf
    +43-1-4277-61808
    Group Leader
    Nimpf
    2.112
    Main Building
  • Adrian Nogales Moral
    +43-1-4277-61643
    PhD Student
    Köhler A
    3.524
    Main Building
  • O
  • Michael Oberhuemer
    +43-1-4277-74645
    PhD Student
    Leeb
    3.123/3.125
    Main Building
  • Till Pascal Oblau
    +43-1-4277-74371
    Diploma/Master Student
    Menche
    1.104
    Main Building
  • Egon Ogris
    +43-1-4277-61730
    Group Leader
    Ogris
    2.117
    Main Building
  • Julia Okrina
    +43-1-4277-61761
    Weitzer
    2.522
    Main Building
  • Anastasia Okun
    +43-1-4277-61653
    PhD Student
    Karagöz
    3.507/ 3.508
    Main Building
  • Lukas Orel
    +43-1-4277-74636
    Lab Manager
    Tessmar
    4.501
    Main Building
  • Lucija Orlić
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Shotaro Otsuka
    +43-1-4277-61665
    Group Leader
    Otsuka
    3.506
    Main Building
  • Ö
  • Sidar Özer
    +43-1-4277-24042
    IT Support
    2.116
    Main Building
  • O
  • Pedro Ozorio Brum
    +43-1-4277-54616
    PhD Student
    Tessmar
    4.504/4.506
    Main Building
  • P
  • Claudia Pachinger
    +43-1-4277-54621
    PhD Student
    Dammermann
    4.508
    Main Building
  • Michele Paganini
    +43-1-4277-56221
    Klein
    5.528/5.530
    Main Building
  • Nathan Palmer
    +43-1-4277-56231
    PostDoc
    Matos
    5.122/5.123
    Main Building
  • Dimitra Paouneskou
    +43-1-4277-56261
    PostDoc
    Jantsch V
    5.522
    Main Building
  • Paulina Parafiniuk-Borzecki
    +43-1-4277-52801
    Administration
    5.115
    Main Building
  • Rajvi Shashi Patel
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Anzhela Pavlova
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Philipp Penninger
    +43-1-4277-61812
    PhD Student
    Kuchler
    2.107
    Main Building
  • Cassius Manuel Perez de los Cobos Hermosa
    +43-1-4277-74326
    PhD Student
    v. Haeseler
    1.812.5
    VBC 5
  • Lara Veronika Perko Budja
    +43-1-4277-74610
    Diploma/Master Student
    Görke
    4.110
    Main Building
  • Thomas Peterbauer
    +43-1-4277-61676
    Senior Imaging Specialist
    1.618
    VBC 5
  • Jan Petržílek
    +43-1-4277-52801
    PhD Student
    Ameres
    2.122
    Main Building
  • Vasiliki Petroulaki
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Andriy Petryshyn
    +43-1-4277-61812
    Technician
    Kuchler
    2.107
    Main Building
  • Karin Pfeiffer
    +43-1-4277-52201
    Administration
    1.604
    VBC 5
  • Trinh Phan-Canh
    +43-1-4277-24001
    Kuchler
    2.509
    Main Building
  • Lucas Piech
    +43-1-4277-52241
    PhD Student
    Leonard
    1.222
    VBC 5
  • Parvaneh Piran
    +43-1-4277-24004
    Controller
    6.109
    Main Building
  • Sebastian Pirch
    +43-1-4277-74390
    Technician
    Menche
    1803
    VBC 5
  • Mattia Pitasi
    +43-1-4277-61645
    PhD Student
    Leeb
    3.123/3.125
    Main Building
  • Barbara Platzer
    +43-1-4277-52213
    Diploma/Master Student
    Juffmann
    1.722
    VBC 5
  • Anton Polyansky
    +43-1-4277-52271
    Staff Scientist
    Zagrovic
    1.612
    VBC 5
  • Niko Popitsch
    +43-1-4277-24024
    Senior PostDoc
    Ameres
    2.116
    Main Building
  • Hauptgebäude Portier
    +43-1-4277-12894
    1.106
    Main Building
  • Elisabeth Prager
    +43-1-4277-54632
    Diploma/Master Student
    Moll
    4.129
    Main Building
  • Viktoria Prast
    +43-1-4277-56221
    PhD Student
    Klein
    5.528/5.530
    Main Building
  • Friedrich Propst
    +43-1-4277-52858
    Guest Researcher
    Propst
    5.528/5.530
    Main Building
  • Aleksandra Ptaszek
    +43-1-4277-52229
    PhD Student
    Konrat
    0614
    VBC 5
  • Dominic Pühringer
    +43-1-4277-52225
    PhD Student
    Djinovic
    0612
    VBC 5
  • Q
  • Laura Quell
    +43-1-4277-74610
    PhD Student
    Görke
    4.110
    Main Building
  • Irma Querques
    +43-1-4277-74320
    Querques
    1.604
    VBC 5
  • Cristina Quesada Candela
    +43-1-4277-56261
    PostDoc
    Jantsch V
    5.522
    Main Building
  • R
  • Katarina Radisavljevic
    +43-1-4277-61641
    PhD Student
    Köhler A
    3.522
    Main Building
  • Gerald Raffl
    +43-1-4277-74822
    PhD Student
    Ameres
    2.122
    Main Building
  • Florian Raible
    +43-1-4277-54616
    Group Leader
    Raible
    4.115
    Main Building
  • Shiviya Raina
    +43-1-4277-24001
    PhD Student
    Dammermann
    4.508
    Main Building
  • America Ramirez Colmenero
    +43-1-4277-61641
    PhD Student
    Köhler A
    3.522
    Main Building
  • Birgit Rapp
    +43-1-4277-54628
    Lab Manager
    Decker
    4.522/4.524
    Main Building
  • Eva Rasch
    +43-1-4277-52820
    Technician
    5.116
    Main Building
  • Antonio Real-Hohn
    +43-1-4277-61626
    PostDoc
    Dong
    3.127
    Main Building
  • Franziska Reden
    +43-1-4277-74324
    Diploma/Master Student
    v. Haeseler
    1.812.5
    VBC 5
  • Ronja Reinhardt
    +43-1-4277-52275
    PhD Student
    Leonard
    1.321
    VBC 5
  • Wolfgang Ludwig Reiter
    +43-1-4277-52846
    Senior Scientist
    5.10
    IMP/IMBA
  • Kaike REN
    +43-1-4277-61668
    PhD Student
    Otsuka
    3.505
    Main Building
  • Armin Resch
    +43-1-4277-54631
    Lab Manager
    Moll
    4.122/4.124
    Main Building
  • Roger Revilla-i-Domingo
    +43-1-4277-54618
    Senior PostDoc
    Raible
    4.510/4.512
    Main Building
  • Liubov Riabina
    +43-1-4277-54626
    Diploma/Master Student
    Kovarik
    4.514
    Main Building
  • Karl Riepl
    +43-1-4277-none
    Diploma/Master Student
    Menche
    1.722.1
    VBC 5
  • Norma Rivera
    +43-1-4277-61628
    Technician
    Köhler A
    3.527
    Main Building
  • Andrea Rodi
    +43-1-4277-74823
    Diploma/Master Student
    Ameres
    2.122
    Main Building
  • Dunja Rokvic
    +43-1-4277-74636
    Technician
    Tessmar
    4.501
    Main Building
  • Anete Romanauska
    +43-1-4277-61649
    PostDoc
    Köhler A
    3.527
    Main Building
  • Julia Romanov
    +43-1-4277-52805
    Lab Manager
    Martens
    5.502
    Main Building
  • Dagmar Roschitz
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Johann Rotheneder
    +43-1-4277-61720
    Lecturer
    Rotheneder
    2.125
    Main Building
  • Claudia Rudolf
    +43-1-4277-61761
    Technician
    Weitzer
    2.522
    Main Building
  • Harald Rumpler
    +43-1-4277-61810
    Technician
    Nimpf
    2.110
    Main Building
  • Luis Rupp
    +43-1-4277-24001
    Diploma/Master Student
    Witte
    4.125/4.127
    Main Building
  • S
  • Sowmya S Geetha
    +43-1-4277-56250
    PhD Student
    Jantsch V
    5.522
    Main Building
  • Carolina Saad
    +43-1-4277-56241
    PhD Student
    Schlögelhofer
    5.524/5.526
    Main Building
  • Melanie Salek
    +43-1-4277-74645
    Diploma/Master Student
    Leeb
    3.123/3.125
    Main Building
  • Ulrich Salzer
    +43-1-4277-61777
    PostDoc
    Müllner
    2.523
    Main Building
  • Ana Maria Sandru
    +43-1-4277-54629
    PhD Student
    Baccarini
    4.525/4.527
    Main Building
  • Ana Santiago
    +43-1-4277-54629
    Technician
    Baccarini
    4.525/4.527
    Main Building
  • Laura Santini
    +43-1-4277-61645
    PhD Student
    Leeb
    3.123/3.125
    Main Building
  • Fatih Sarigol
    +43-1-4277-61671
    Technician
    Foisner
    3.108
    Main Building
  • Florian Sauer
    +43-1-4277-52242
    Diploma/Master Student
    Juffmann
    1.211
    VBC 5
  • Thomas Sauer
    +43-1-4277-61782
    Facility Manager
    2.530
    Main Building
  • Justyna Sawa-Makarska
    +43-1-4277-52805
    PostDoc
    Martens
    5.502
    Main Building
  • Yvonne Scamarcia
    +43-1-4277-52263
    Diploma/Master Student
    Djinovic
    0114
    VBC 5
  • Federico Scaramuzza
    +43-1-4277-74636
    PhD Student
    Tessmar
    4.501
    Main Building
  • Stefan Schaar
    +43-1-4277-52828
    Diploma/Master Student
    Martens
    5.502
    Main Building
  • Petra Schaffer
    +43-1-4277-74636
    Diploma/Master Student
    Tessmar
    4.504/4.506
    Main Building
  • Sonja Schauer
    +43-1-4277-56241
    Apprentice
    Schlögelhofer
    5.524/5.526
    Main Building
  • Natascha Scherzer
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Alexandra Schilder
    +43-1-4277-74610
    PhD Student
    Görke
    4.110
    Main Building
  • Lukas Schindler
    +43-1-4277-56241
    Diploma/Master Student
    Schlögelhofer
    5.524/5.526
    Main Building
  • Peter Schlögelhofer
    +43-1-4277-56240
    Group Leader
    Schlögelhofer
    5.623
    Main Building
  • Maximilian Schmid
    +43-1-4277-52807
    Diploma/Master Student
    Slade
    5.508
    Main Building
  • Heiko Schmidt
    +43-1-4277-74321
    Senior PostDoc
    v. Haeseler
    1.812.1
    VBC 5
  • Leon Schmidt
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Marketa Schmidt Cernohorska
    +43-1-4277-54619
    PostDoc
    Dammermann
    4.508
    Main Building
  • Rebecca Schneeweiss
    +43-1-4277-52807
    Diploma/Master Student
    Slade
    5.508
    Main Building
  • Maren Schneider
    +43-1-4277-61643
    Staff Scientist
    Köhler A
    3.524
    Main Building
  • Valentin Schober
    +43-1-4277-56240
    Diploma/Master Student
    Schlögelhofer
    5.524/5.526
    Main Building
  • Julia Scholz
    +43-1-4277-61668
    PhD Student
    Otsuka
    3.505
    Main Building
  • Manuel Schön
    +43-1-4277-74636
    Diploma/Master Student
    Tessmar
    4.117
    Main Building
  • Denise Schratt
    +43-1-4277-54632
    Diploma/Master Student
    Moll
    4.129
    Main Building
  • Claudia Schreiner
    +43-1-4277-52233
    Lab Manager
    Djinovic
    0124
    VBC 5
  • Dominik Schrempf
    +43-1-4277-74328
    PostDoc
    v. Haeseler
    1.812.3
    VBC 5
  • Stefan Schuechner
    +43-1-4277-61731
    PostDoc
    Ogris
    2.127
    Main Building
  • Martina Schuschnig
    +43-1-4277-52838
    Technician
    Martens
    5.401
    Main Building
  • Irene Schwartz
    +43-1-4277-54614
    PhD Student
    Versteeg
    4.108
    Main Building
  • Thomas Schwarz
    +43-1-4277-52263
    PostDoc
    Konrat
    0114
    VBC 5
  • Alois Schweighofer
    +43-1-4277-76528
    6.111a
    Main Building
  • Ś
  • Grzegorz Ścibisz
    +43-1-4277-61653
    PhD Student
    Karagöz
    3.507/ 3.508
    Main Building
  • S
  • Maximilian Seitl
    +43-1-4277-61761
    Weitzer
    2.522
    Main Building
  • Michaela Sekljic
    +43-1-4277-24001
    Administration
    6.108
    Main Building
  • Katharina Semrad
    +43-1-4277-54692
    5.527
    Main Building
  • Annamaria Sgromo
    +43-1-4277-74822
    PostDoc
    Ameres
    2.122
    Main Building
  • Mili Shah
    +43-1-4277-52857
    Lab Manager
    5.116
    Main Building
  • Varun Sharma
    +43-1-4277-74371
    PhD Student
    Menche
    1803
    VBC 5
  • Sanskriti Sharma
    +43-1-4277-74648
    PhD Student
    Ellis
    3.118
    Main Building
  • Stephen Shoebridge
    +43-1-4277-52828
    Technician
    Martens
    5.502
    Main Building
  • Alexandra Shulkina
    +43-1-4277-54614
    PhD Student
    Versteeg
    4.108
    Main Building
  • Dhanlakshmi Shunmugam
    +43-1-4277-54629
    PhD Student
    Baccarini
    4.529
    Main Building
  • Emilia Sieberth
    +43-1-4277-74645
    Diploma/Master Student
    Leeb
    3.123/3.125
    Main Building
  • Florian Sikora
    +43-1-4277-74610
    PhD Student
    Görke
    4.110
    Main Building
  • Raquel Silva
    +43-1-4277-61673
    PhD Student
    Foisner
    3.108
    Main Building
  • Celine Sin
    +43-1-4277-74390
    PostDoc
    Menche
    1803
    VBC 5
  • Timothy Skern
    +43-1-4277-61620
    Group Leader
    Skern
    3.118
    Main Building
  • Dea Slade
    +43-1-4277-52811
    Group Leader
    Slade
    5.610
    Main Building
  • Melanie Slezak
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Adrian Söderholm
    +43-1-4277-54614
    PhD Student
    Versteeg
    4.108
    Main Building
  • Elisabeth Sonnleitner
    +43-1-4277-54631
    Lecturer
    Moll
    4.122/4.124
    Main Building
  • Anna Souchet
    +43-1-4277-61681
    Foisner
    3.110
    Main Building
  • Rita Stadler
    +43-1-4277-56200
    Administration
    5.115
    Main Building
  • Alexander Stadler
    +43-1-4277-61704
    Technician
    Ogris
    2.127
    Main Building
  • Moritz Staltner
    +43-1-4277-52801
    PostDoc
    Ameres
    2.122
    Main Building
  • Elisa Stanescu
    +43-1-4277-54632
    Diploma/Master Student
    Moll
    4.129
    Main Building
  • Nina Stanisic
    +43-1-4277-52808
    Campbell
    5.512/5.513
    Main Building
  • Edvinas Stankunas
    +43-1-4277-61628
    PhD Student
    Köhler A
    3.527
    Main Building
  • Sonja Steindl
    +43-1-79044-
    Diploma/Master Student
    Swarts
    1.722.1
    VBC 5
  • Florian Steiner
    +43-1-4277-61761
    Diploma/Master Student
    Weitzer
    2.522
    Main Building
  • Mirjam Stelzer
    +43-1-4277-
    Diploma/Master Student
    Moll
    4.129
    Main Building
  • Alexander Stockinger
    +43-1-4277-74636
    PhD Student
    Raible
    4.501
    Main Building
  • Katharina Stoppacher
    +43-1-4277-56201
    Administration
    5.115
    Main Building
  • Johanna Stranner
    +43-1-4277-52857
    Technician
    5.116
    Main Building
  • Samuel Strobel
    +43-1-4277-61730
    Diploma/Master Student
    Ogris
    2.127
    Main Building
  • Xue Strobl
    +43-1-4277-52807
    PhD Student
    Slade
    5.508
    Main Building
  • Ioanna Styliara
    +43-1-4277-61653
    Diploma/Master Student
    Karagöz
    3.502
    Main Building
  • Tiffany Su
    +43-1-4277-54621
    PhD Student
    Dammermann
    4.508
    Main Building
  • Kelly Swarts
    +43-1-4277-74320
    Group Leader
    Swarts
    1.722
    VBC 5
  • Magdaena Swoboda
    +43-1-4277-61704
    Ogris
    2.127
    Main Building
  • T
  • Markus Teige
    +43-1-4277-57719
    Lecturer
    5.110
    Main Building
  • Kristin Teßmar-Raible
    +43-1-4277-74635
    Group Leader
    Tessmar
    4.117
    Main Building
  • Magdalena Teufl
    +43-1-4277-61809
    Technician
    Nimpf
    2.110
    Main Building
  • Henry Thomas
    +43-1-4277-74647
    PhD Student
    Bücker
    3.510/3.512
    Main Building
  • Stefanie Toifl
    +43-1-4277-54630
    PhD Student
    Baccarini
    4.529
    Main Building
  • Fotima Touraeva
    +43-1-4277-
    Technician
    Decker
    4.522/4.524
    Main Building
  • Aleksandr Tsarev
    +43-1-4277-52801
    PhD Student
    Ameres
    2.112
    Main Building
  • Irina Tsymala
    +43-1-4277-61811
    PhD Student
    Kuchler
    2.107
    Main Building
  • Susanna Tulli
    +43-1-4277-52838
    Martens
    5.401
    Main Building
  • Hans Tuppy
    +43-1-4277-61670
    Group Leader
    3.617
    Main Building
  • Tatiana Tyshchuk
    +43-1-4277-52801
    Diploma/Master Student
    Ameres
    2.125
    Main Building
  • U
  • Amol Ugale
    +43-1-4277-54629
    PostDoc
    Baccarini
    4.529
    Main Building
  • V
  • Miguel Vallebueno
    +43-1-79044-9000
    PostDoc
    Swarts
    1.722.1
    VBC 5
  • Gina Varnavides
    +43-1-4277-24001
    Student assistant
    5.10
    IMP/IMBA
  • Jiri Veis
    +43-1-4277-52826
    PostDoc
    Ogris
    2.122
    Main Building
  • Daniel Velikov
    +43-1-4277-56231
    Diploma/Master Student
    Matos
    5.122/5.123
    Main Building
  • Gijs Versteeg
    +43-1-4277-54637
    Group Leader
    Versteeg
    4.009
    Main Building
  • Magdalena Vesely
    +43-1-4277-56221
    Technician
    Klein
    5.528/5.530
    Main Building
  • Alexander Vogel
    +43-1-4277-74340
    PhD Student
    Yudushkin
    1.612
    VBC 5
  • Tamara Völkerer
    +43-1-4277-61668
    Lab Manager
    Otsuka
    3.505
    Main Building
  • Isabella Völkl
    +43-1-4277-74647
    PhD Student
    Bücker
    3.510/3.512
    Main Building
  • Arndt von Haeseler
    +43-1-4277-74307
    Group Leader
    v. Haeseler
    1.107
    VBC 5
  • Denise Vorauer
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Georg Vucak
    +43-1-4277-54629
    PhD Student
    Baccarini
    4.525/4.527
    Main Building
  • Loan Vulliard
    +43-1-4277-74371
    PhD Student
    Menche
    1803
    VBC 5
  • Milica Vunjak
    +43-1-4277-54614
    PhD Student
    Versteeg
    4.108
    Main Building
  • W
  • Lynn Wachelder
    +43-1-4277-61626
    Dong
    3.127
    Main Building
  • Lea Wallner
    +43-1-4277-52808
    Campbell
    5.512/5.513
    Main Building
  • Christa Walther
    +43-1-4277-24005
    Imaging Specialist - Superresolution Microscopy
    1.618
    VBC 5
  • Vanessa Wegert
    +43-1-4277-74825
    Lab Manager
    Ameres
    2.126
    Main Building
  • Lisa Weidlich
    +43-1-4277-74320
    Diploma/Master Student
    Swarts
    1.722.1
    VBC 5
  • Stefan Weitzer
    +43-1-4277-61815
    PostDoc
    Martinez
    2.512
    Main Building
  • Georg Weitzer
    +43-1-4277-61717
    Group Leader
    Weitzer
    2.118
    Main Building
  • Rahel Wettstein
    +43-1-4277-56231
    Senior PostDoc
    Matos
    5.122/5.123
    Main Building
  • Gerhard Wiche
    +43-1-4277-52852
    Lecturer
    Wiche
    5.028
    Main Building
  • Katharina Wieland
    +43-1-4277-56221
    Klein
    5.528/5.530
    Main Building
  • Helga Wieltschnig
    +43-1-4277-61701
    Administration
    2.115
    Main Building
  • Katharina Wiener
    +43-1-4277-61645
    Diploma/Master Student
    Leeb
    3.123/3.125
    Main Building
  • Johannes Wieser
    +43-1-4277-24042
    IT Support
    5.119
    Main Building
  • Leonhard Wiesinger
    +43-1-4277-74636
    Diploma/Master Student
    Tessmar
    4.501
    Main Building
  • Nikola Winter
    +43-1-4277-52810
    PostDoc
    Bachmair
    5.108/5.109
    Main Building
  • Sabina Winter
    +43-1-4277-61601
    Administration
    3.115
    Main Building
  • Angela Witte
    +43-1-4277-54643
    Lecturer
    Witte
    4.128
    Main Building
  • Uyen Wolff
    +43-1-4277-56261
    PhD Student
    Jantsch V
    5.522
    Main Building
  • Bernhard Wurzinger
    +43-1-4277-52810
    PostDoc
    Bachmair
    5.108/5.109
    Main Building
  • X
  • Martin Xaver
    +43-1-4277-56231
    PostDoc
    Matos
    5.122/5.123
    Main Building
  • Y
  • Bugra Yaman
    +43-1-4277-61821
    Martinez
    2.512
    Main Building
  • Chun-Chieh Yen
    +43-1-4277-74320
    PhD Student
    Swarts
    1.722.1
    VBC 5
  • Irena Yordanova
    +43-1-4277-61777
    Müllner
    2.523
    Main Building
  • Ivan Yudushkin
    +43-1-4277-74340
    Lecturer
    Yudushkin
    1.612
    VBC 5
  • Z
  • Bojan Zagrovic
    +43-1-4277-52271
    Group Leader
    Zagrovic
    1.601
    VBC 5
  • Christina Zeiler
    +43-1-4277-54626
    PhD Student
    Kovarik
    4.516
    Main Building
  • Anna Zvereva
    +43-1-4277-52810
    PostDoc
    5.108/5.109
    Main Building
  • Ilia Zykov
    +43-1-4277-52213
    PhD Student
    Juffmann
    1.722
    VBC 5

office@maxperutzlabs.ac.at

+43 1 4277 240 01
Today: 9am - 5pm

Vienna Biocenter (VBC)
Dr.-Bohr-Gasse 9, 1030 Vienna